US20080017800A1 - Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation - Google Patents

Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation Download PDF

Info

Publication number
US20080017800A1
US20080017800A1 US11/864,203 US86420307A US2008017800A1 US 20080017800 A1 US20080017800 A1 US 20080017800A1 US 86420307 A US86420307 A US 86420307A US 2008017800 A1 US2008017800 A1 US 2008017800A1
Authority
US
United States
Prior art keywords
light
transducer
laser
light source
housing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/864,203
Inventor
Paul Benni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAS Medical Systems Inc
Original Assignee
CAS Medical Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAS Medical Systems Inc filed Critical CAS Medical Systems Inc
Priority to US11/864,203 priority Critical patent/US20080017800A1/en
Assigned to CAS MEDICAL SYSTEMS, INC. reassignment CAS MEDICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BENNI, PAUL
Publication of US20080017800A1 publication Critical patent/US20080017800A1/en
Assigned to HEALTHCARE FINANCIAL SOLUTIONS, LLC (AS SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT reassignment HEALTHCARE FINANCIAL SOLUTIONS, LLC (AS SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CAS MEDICAL SYSTEMS, INC.
Assigned to SOLAR CAPITAL LTD., AS SUCCESSOR AGENT reassignment SOLAR CAPITAL LTD., AS SUCCESSOR AGENT ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS RETIRING AGENT
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14553Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552Details of sensors specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6814Head
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0242Operational features adapted to measure environmental factors, e.g. temperature, pollution

Definitions

  • This invention relates to an improvement in a non-invasive near-infrared spectrophotometric (NIRS) optical transducer assembly, and a method of using the same. More particularly, this invention relates to a practical NIRS optical transducer assembly which can be reusable, is safe to use, and which can provide an accurately sized and consistent laser light field on a subject's skin.
  • NIRS near-infrared spectrophotometric
  • NIRS Near-infrared spectroscopy
  • HbO 2 oxygenated-hemoglobin
  • Hb deoxygenated-hemoglobin
  • the most valuable aspect of NIRS is that it allows one to continually monitor cerebral oxygenation levels in an adult or neonate, especially in diseased conditions, in which oxygenation levels in the brain can be compromised, leading to brain damage or death.
  • NIRS Near-infrared spectroscopy
  • pulse oximetry determines arterial oxygen saturation (SaO 2 ) of peripheral tissue (i.e. finger, ear, nose) by monitoring pulsatile optical attenuation changes of detected light induced by pulsatile arterial blood volume changes in the arteriolar vascular system.
  • SaO 2 arterial oxygen saturation
  • the method of pulse oximetry requires pulsatile blood volume changes in order to make a measurement. Since venous blood is not pulsatile, pulse oximetry cannot provide any information about venous blood. Conversely, NIRS does not require pulsatile blood volume to calculate parameters of clinical value.
  • Relative changes of the concentrations of HbO 2 and Hb can be quantified by using the modified Beer-Lambert Law, which takes into account the optical attenuation in a highly scattering medium like biological tissue.
  • A is the optical attenuation in tissue at wavelength L (units: optical density OD); I 0 is the incident light intensity (units: Wlcm 2 ); I is the detected light intensity; (L is the wavelength-dependent absorption coefficient of the chromophore (units: OD ⁇ cm ⁇ 1 ⁇ M ⁇ 1 ); C is the concentration of chromophore (units: ⁇ M); d is the light source-to-detector distance (units: cm); B is the light scattering differential path length factor (unitless); and G is a factor relating to tissue geometry and scattering of light (units: OD).
  • NIRS algorithms that are designed to calculate the relative changes of more than one chromophore use the multivariate form of Equation 2.
  • ⁇ HbO 2 oxyhemoglobin
  • ⁇ Hb deoxyhemoglobin
  • ⁇ M ⁇ M
  • a reusable NIRS transducer assembly having the ability to accurately control the energy level and size of a laser light field cast upon a subject's skin as well as improving the light detector signal-to-noise ratio by employing an improved EMI shielding scheme during use of the assembly. It would be desirable to combine light from multiple light sources into a single output fiber optic that is lightweight, and flexible, while providing sufficient light coupling efficiency. It would be desirable to have a transducer dislodgement-laser safety interlock system that would require no extra light source or detector components, while having the ability to disable laser operation due to transducer attachment failure and laser operation failure as well as a scheme that will verify secure transducer attachment before laser activation.
  • This invention relates to an improved transducer assembly for use in near-infrared spectroscopy (NIRS) of human patients.
  • a prism providing a laser light source directing means, and one or more photodiodes are contained in a flexible housing which can be easily and securely attached to a subject's head, or some other part of the body.
  • a rigid light guide placed over the prism provides a constant light intensity output of the spectrophotometric measuring system during a measuring period, by maintaining a constant laser light source to skin distance.
  • a light detection means by utilizing one or more photodiodes, allows for detection of laser light at a predetermined distance(s) away from the light source.
  • the detection of light is improved by implementing an EMI shielding scheme that allows for attenuation of EMI interference while preserving an optical pathway for light to reach the detector via an EMI shielded optically transparent rigid window.
  • An improved method of combining light from multiple light sources into a single output fiber optic that is lightweight, and flexible, while providing sufficient light coupling efficiency for a spectrophotometric measuring system is disclosed.
  • An improved transducer dislodgement-laser safety interlock system is disclosed which does not require extra light source or detector components, while having the ability to disable laser operation due to transducer attachment failure and laser operation failure as well as verifying secure transducer attachment before laser activation.
  • the NIRS transducer assembly of this invention may consist of two separable components, the NIRS transducer housing containing the laser light source and photodiode(s) described above; and a disposable adhesive envelope or pad which is used to mount the NIRS transducer assembly housing easily and securely to the subject's skin. It is economically more feasible to use a non-disposable NIRS transducer housing with a disposable envelope rather than a disposable NIRS transducer housing, while maintaining all of the advantages of single use, disposable transducer applications, especially in a health care environment, in which sanitation and sterilization requirements are paramount.
  • the rigid laser light guide which is placed over the output window of the laser light redirecting prism, has several functions.
  • One function is to further decrease the intensity of laser light on the skin of a subject undergoing spectrophotometric monitoring by taking advantage of the conical radiation characteristics of the laser diode coupled to a optical light guide such as a multimode or single mode fiber optic.
  • a optical light guide such as a multimode or single mode fiber optic.
  • the laser light guide is rigid and provides a planar interface between the assembly and the patients skin in which the laser light is illuminating.
  • the light guide controls the spacing between the prism and the subject's skin, and therefore controls the incident light intensity I 0 (from Equation 1) on the subject's skin. This is especially important when attempting to measure absolute chromophore values as determined from Equation 1.
  • One or more photodiodes are also incorporated in the NIRS transducer assembly housing, separated from the laser diodes light source by from a few mm to more than about 60 mm, depending on the size of the subject being monitored. For a typical adult human head, it is believed that at least 45 mm separation distance is needed for adequate brain blood oxygenation monitoring, using a reflection mode type of the NIRS transducer assembly. Multiple photodiodes can be used to monitor different depths of blood oxygenation in the subject, or can be used as reference detectors for algorithms that compensate for the scalp component of the detected signals.
  • Photodiodes with larger surface areas can be used as the laser light source-to-photodiode separation distances increase to compensate for the decreasing light levels detected from larger separation distances or lower power light sources.
  • a photodiode preamplifier placed next to the photodiode, or farther away as a separate assembly, allows for amplification of the detected low light level signal, and then provides the amplified signal to the NIRS system processor.
  • a partially optically transparent, and electrically conductive shield which surrounds the photodiode can be used to attenuate ambient electromagnetic interference (EMI) noise which is otherwise transmitted to the photodiode.
  • EMI ambient electromagnetic interference
  • a window in the shield exposes the photodiode's photosensitive surface to detected light from the laser diodes.
  • the optically transparent electrically conductive shield may include a thin metal wire screen, an electrically conductive transparent coating, or the like.
  • a disposable adhesive envelope or pad for the purpose of securing the NIRS transducer assembly housing to the subject's skin renders the transducer assembly housing reusable from subject to subject.
  • the disposable adhesive envelope or pad can be pre-sterilized thereby providing additional protection to the subject.
  • the disposable envelope or pad will also protect the NIRS transducer assembly housing from any residue from the subject, allowing the NIRS probe housing surface to remain uncontaminated, thus making it safer and easier to reuse.
  • Different NIRS transducer assemblies are designed to be interchangeable with different NIRS system processors/monitors by incorporation of custom laser diode drivers and encoded calibration parameters in a connector housing.
  • the NIRS system processor has an interface port for the connector housing.
  • the connector housing may contain customized laser diode automatic power control (APC) drivers, which are individually adjusted to provide a predetermined laser diode output power.
  • APC laser diode automatic power control
  • the NIRS system processor can determine the characteristics of each individual NIRS transducer and laser diode characteristics by a decoding mechanism, calibrating the NIRS algorithm to provide accurate computation with different transducer assemblies and individual laser diode characteristics.
  • a single core multimode fiber optic is used as a light guide to transfer laser light from a detachable connector to the prism inside the transducer housing.
  • a multi-fiber optic combiner assembly channels light from multiple laser light sources into a single fiber optic by utilizing two ball lenses of predetermined characteristics.
  • the advantage of using a ball lens multi-fiber optic combiner is that a smaller diameter single core multimode output fiber optic can be used.
  • Use of a smaller core fiber optic in the cable interfacing the NIRS transducer housing to the detachable connector reduces weight, increases flexibility, and reduces induced torque from bending.
  • the incorporation of several laser safety interlock schemes further minimizes the possibility of unnecessary laser light exposure to personnel using the optical transducer.
  • the safety interlock system inhibits laser diode pulsing immediately if the optical transducer is not securely attached to the subject.
  • the three interlock schemes include: 1) monitoring ambient light conditions; 2) monitoring laser output range; and 3) monitoring sudden changes in detected laser output over a period of time.
  • the detected ambient light level is low because the probe body shields outside light.
  • the detected ambient light reaches a predetermined level, indicating possible transducer detachment or improper placement, laser operation is inhibited. Accidental probe detachment will automatically shut down the laser diodes.
  • additional interlock systems are employed.
  • the light detector in the optical transducer continuously monitors the laser diode output. If the detected laser signal falls out of a predetermined range, then immediate laser shutdown occurs. Also, if the detected laser signal suddenly changes a predetermined amount over a predetermined time period due to probe disruption or detachment, immediate laser shutdown will occur. Any event that indicates probe detachment will require user intervention to re-attach the probe and to reset the NIRS system laser safety interlock before laser diode pulsing can resume.
  • FIG. 1 is a plan view of one embodiment of a reflective NIRS transducer assembly which is formed in accordance with this invention
  • FIG. 2 is a side sectional view of the transducer assembly of FIG. 1 ;
  • FIG. 3 is a view of the light source portion of the embodiment of FIG. 2 ;
  • FIG. 4 is an enlarged sectional view showing the relationship between the transducer assembly fiber optic laser light source, prism, and rigid light guide with the subject's skin;
  • FIG. 5 is an enlarged sectional view of the photodiode portion of the transducer assembly of FIG. 2 showing details of the wire mesh type EMI shielding mechanisms for the photodiodes;
  • FIG. 5A is an enlarged sectional view of the photodiode portion of the transducer assembly of FIG. 2 showing details of the electrically conductive thin film type EMI shielding mechanisms for the photodiodes;
  • FIG. 6 is an enlarged plan view of the EMI shielded photodiode portion of the transducer assembly of FIG. 2 ;
  • FIG. 7 is an enlarged sectional view of an alternative photodiode packaging showing details of the EMI shielding mechanisms
  • FIG. 8 is an enlarged sectional view of the photodiode with preamplifier amplifier showing details of the EMI shielding mechanisms employed;
  • FIG. 9 is a plan view of a disposable self-adhesive envelope which is designed for use in containing the transducer assembly housing of FIG. 1 ;
  • FIG. 10 is a plan view of a disposable self-adhesive pad which is designed for use in connection with the transducer assembly housing of FIG. 1 ;
  • FIG. 11 is a plan view of another embodiment of a reflective NIRS transducer, in which the fiber optic and shielded cable leads exit at an angle of 90° from the configuration shown in FIG. 1 to form an “L”-shaped housing.
  • FIG. 11A shows how the “L”-shaped NIRS transducer of FIG. 11 is attached to a neonate's head.
  • FIG. 12 is a plan view of another embodiment of a transmissive NIRS transducer assembly which is formed in accordance with this invention.
  • FIG. 13 is a schematic view of a NIRS transducer assembly formed in accordance with this invention which is associated with a connector housing, laser box assembly, encoding and decoding means of calibration parameters, and a NIRS system processor;
  • FIG. 14 is schematic view of a NIRS transducer assembly which is similar to FIG. 13 , but showing partitioned laser power control drivers and the pre-amp portion of the system located in the assembly housing;
  • FIG. 15 is a light ray diagram of the multi-fiber optic light combiner assembly
  • FIG. 16 shows the details of the multi-fiber optic light combiner assembly
  • FIG. 17 shows details of the assembly process of the multi-fiber optic light combiner
  • FIG. 18 shows the details of the employed laser safety interlock scheme displayed in flowchart form during normal operation of the NIRS transducer/monitor system processor.
  • the transducer assembly 2 includes a housing 4 which contains the components of the transducer assembly 2 .
  • the housing 4 includes a flexible light-shielding surface rubber layer 6 having a first window 8 allowing light to reach the EMI shielded photodiode assembly 18 which is disposed in the housing 4 .
  • the surface layer 6 is made of a durable material to allow attachment and removal of a disposal adhesive attachment method.
  • a laser light guide 28 is overlying and optically coupled to the prism 30 , which protrudes slightly from surface layer 6 .
  • the sides of photodiode window 8 and light guide 28 perpendicular to surface layer 6 are painted with a light-shielding material to prevent optical shunting, i.e., light from entering through the sides of the windows.
  • the surface of window 8 and light guide 28 are flush with the exposed surface of surface layer 6 .
  • Fiber optics 39 direct light from remotely located laser diodes to the prism 30 and are secured in place by the fiber optic mount 27 .
  • the housing 4 also includes a flexible, electrically and optically insulating body 24 which can be formed from rubber or some other suitable elastomer, attached to a flexible support structure 26 .
  • the light source assembly 20 , the EMI-shielded photodiode assembly 18 , and surface layer 6 are also mounted on the flexible support structure 26 .
  • Another shielded cable 38 interconnects the photodiode assembly 18 and the NIRS system processor assembly via an interface connector housing (See FIG. 13 ).
  • the NIRS system processor analyzes the results of the NIRS reflectance data gathered by the photodiode 10 .
  • the light redirecting prism 30 is connected to the rigid light guide 28 which provides surface-to-surface contact between the prism 30 and the subject's skin S.
  • the light guide 28 is rigid so that when it is pressed against the subject's skin during the monitoring of blood oxygen, the surface S of the skin is flattened, and the distance between the fiber optic 39 output and the skin surface S via the prism 30 is constant across the entire illuminated area of the skin.
  • FIG. 4 Shown in FIG. 4 are the arrangements of the light guide 28 and prism 30 demonstrating how the distance “r” between the laser coupled fiber optic 39 output and the surface S of the subject's skin can be controlled.
  • the planar surface S′ of the light guide 28 when pressed against the subject's skin S, will flatten the contacted area of the subject's skin S so that the distance “r” between the laser coupled fiber optic 39 and the subject's skin S is constant for the entire skin area which is illuminated by the light guide 28 .
  • the inclusion of the light guide 28 with the prism 30 results in the effective length of “r” since r r 1 +r 2 +r 3 .
  • the light guide 28 may include a selective filter 29 .
  • the selective filter 29 may consist of a light-attenuating neutral density filtering element, or a light-diffusive element, such as a milky white semi-transparent plastic material, or both, in combination.
  • FIGS. 5, 5A , and 6 illustrate an ambient EMI shielding arrangement for the photodiode detector window 8 .
  • An EMI shielded and optically transparent pane 32 of predetermined thickness is positioned over the light sensitive surface 34 of the photodiode detector 10 .
  • the photodiode detector 10 includes a light-sensitive element 9 which is disposed in a ceramic cup 11 .
  • a wire mesh 36 is embedded between two optically transparent members 31 and 33 , which form the pane 32 . The mesh 36 will allow at least about 60% optical transmission of the reflected light from the laser light source 20 after passage through biological tissue to reach the photodiode 10 .
  • a non-porous EMI shield 37 such as an electro-conductive metal foil, surrounds the non-light sensitive parts of the housing, including the photodiode lead 23 .
  • An electrically conductive gasket 40 such as silicone paste, adhesive, foam, or other similar material, is used to create an electrical interface between the wire mesh 36 of the EMI shielded pane 32 and the non-porous EMI shield 37 .
  • the wire mesh 36 could be placed directly over the photodiode light sensitive surface 34 , and an optically transparent, electrically insulating pane 32 having a predetermined thickness, formed from a material such as glass, could then be placed over the wire mesh 36 .
  • FIG. 5A shows an alternative embodiment in which the wire mesh 36 and lower optical member 33 are replaced with a thin optical member 48 that is coated with an electrically conductive, optically transparent thin film on one side.
  • the electrically conductive film of thin optical member 48 is electrically interfaced to the non-porous EMI shield 37 by electrically conductive epoxy, adhesive, paste, or the like.
  • the optical member 31 may be coated with an electrically conductive, optically transparent thin film on the side facing the photodiode 10 .
  • FIG. 7 shows how a photodiode packaged in the “can” style package 45 can be EMI shielded by applying a wire mesh or thin film EMI shield 41 over the photodiode package “can” aperture. An electrically insulating, optically transparent window 43 would then cover the EMI shield 41 .
  • FIG. 8 shows a preamplifier 76 placed next to photodiode 10 , and enclosed in the EMI shielding structures similar to those described in FIG. 5 through FIG. 7 .
  • the wire mesh 36 or electrically conductive film 48 in combination with the non-porous electro-conductive material 37 creates a Faraday Cage around the photodiode 10 , while allowing light to reach the photodiode 10 light-sensitive surface 34 .
  • an EMI attenuating optically transparent pane 32 of a predetermined thickness preferably of about 1 mm or greater, further EMI attenuation is attained by increasing the photodiode-to-biological tissue separation distance.
  • This optically transparent spacer reduces the capacitance between the photodiode light sensitive surface 34 and the biological tissue, such as human skin, resulting in the increased reduction in electromagnetic coupling and generated noise currents when compared to using the Faraday Cage shielding method without the optical spacer.
  • EMI shielded wire mesh windows from Chomerics (Woburn, Mass.) can be used.
  • Chomerics “EMI CLARE”TM GP 70 EMI shielded windows provide 60 to 70% light transmission, with different pane thicknesses of 1.66 mm; 2.00 mm; and 3.00 mm being available.
  • the transparent panes 32 and the mesh 36 need to be sized to close the window 8 and cover the light-sensitive surface 34 of the photodiode 10 , which surface 34 can range in size from four square mm to one hundred square mm.
  • Chomerics “WIN-SHIELD”TM AgF8 conductive film can be used in place of the wire mesh window.
  • This conductive film is 0.2 mm thick and has similar optical properties as the mesh window.
  • a copper mesh wire cloth like material from Sefar America, Inc. (Briarcliff Manor, N.Y.) can be used as an EMI shield over the photodiode photosensitive surface.
  • FIG. 9 shows an envelope 42 which can be used to house the assembly 2 .
  • the envelope 42 has two transparent plastic windows or open apertures 44 and 46 which are sized and positioned to be in registry with light source assembly 20 , and with the photodiode assembly 18 , respectively.
  • the transducer assembly 2 is inserted into the envelope 42 through an opening 48 .
  • the transparent window version of envelope 42 is used if the rigid laser light guide 28 and photodiode window 32 are flush with upper surface layer 6 .
  • the open aperture window version of envelope 42 is used if the rigid laser light guide 28 and photodiode window 32 protrude slightly from the upper surface layer 6 as shown in FIG. 1 , with the respected windows locking into place.
  • the envelope 42 also includes several clasps 50 that are used to secure the assembly 2 in place in the envelope 42 .
  • the surface 52 of the envelope 42 is formed from, or coated with, an adhesive material.
  • the envelope 42 is preferably formed from a light-impermeable material such as rubber or black plastic. This prevents light from directly traveling between the laser diodes and the photodiode (i.e., no optical shunting) which could occur with a transparent envelope.
  • FIG. 10 shows a disposable or discardable adhesive pad 54 which can be releasably adhered to the transducer assembly 2 and to the subject's skin.
  • the pad 54 is preferably formed from rubber or black plastic, and includes opposed adherent surfaces such as 60 which enable the pad 54 to be adhered to the transducer assembly 2 and to the subject's skin S.
  • the pad 54 has two transparent plastic windows or open apertures 56 and 58 which are sized and positioned to be in registry with the light source assembly 20 , and with the EMI shielded photodiode assembly 18 , respectively.
  • the transparent window version of pad 54 is used if the rigid laser light guide 28 and photodiode window 32 are flush with upper surface layer 6 .
  • the open aperture window version of pad 54 is used if the rigid laser light guide 28 and photodiode window 32 protrude slightly from the upper surface layer 6 as shown in FIG. 1 , with the respective windows fitting through their respective open apertures.
  • the envelope 42 and the pad 54 are both sterile prior to use, and can be discarded after being removed from the patient.
  • FIG. 11 shows an alternative embodiment of the NIRS transducer assembly of FIG. 1 in which the fiber optic light guide 39 and shielded cable 38 exit the transducer housing 4 on the side, giving the probe assembly an “L” shape.
  • a support appendage 21 further secures the fiber optics 39 and cable 38 to the transducer housing 4 .
  • Recessed cutouts 7 in the housing 4 as shown allow for added flexibility of the optical transducer 2 when applied to curved surfaces such as the head or body appendage.
  • This “L”-shaped NIRS optical transducer is especially useful for brain oxygenation monitoring on awake neonates and awake adults by allowing the fiber optics 39 and cable 38 to come off the subject over the crown of the head (see FIG.
  • the fiber optics 39 and cable 38 are out of grasping range of a neonate's hand, reducing possible transducer disturbance. Also, the transducer is less likely to be disturbed when the neonate sleeps on his or her side, which may result in the neonate sleeping on the NIRS transducer fiber optic-shielded cable leads.
  • FIG. 12 shows an embodiment of a NIRS transducer assembly formed in accordance with this invention which is suitable for use with neonates.
  • the EMI shielded photodiode assembly 18 is contained on one shielded pod 13
  • the light source assembly 20 is contained in another pod 15 .
  • the pods 13 and 15 are connected by the cable 38 , and the fiber optic cable 39 extends from the pod 15 to the controller.
  • the length of the cable 38 is sufficient to allow the pods 13 and 15 to be attached to opposite sides of the neonate's head to allow the monitoring of cerebral blood oxygenation.
  • FIG. 13 illustrates the components of a NIRS transducer assembly connector housing 62 which enables interchangeability of the laser diodes and other components.
  • the laser box housing 90 contains laser diode automatic power control drivers 64 which interface with the laser diodes 14 .
  • a laser diode sequencer control 66 forms a portion of the NIRS system processor 68 and provides multiplexed pulsing of the laser diodes 14 .
  • Each laser diode power output is adjusted by its respective automatic power control driver.
  • incorporation of the automatic power control drivers 64 in the laser box housing 90 provides flexibility in the selection of the laser diodes 14 .
  • the laser box housing 90 also contains a calibration parameter encoding mechanism 70 , along with NIRS transducer encoded parameter mechanism 92 , which provides the NIRS system processor with necessary information relating the laser box housing and NIRS transducer assembly characteristics.
  • the calibration parameters include: laser diode wavelength; coefficients relating to the change in laser diode wavelength over temperature changes; laser diode automatic power control feedback monitor current and corresponding laser power output; transducer light source to photodiode separation distance; encoding coefficients indicating the type of NIRS transducer specifically intended to be used on a certain type of biological tissue, subject body part, or certain subject species; and other information as needed about the characteristics of the individual NIRS transducer assembly being employed.
  • the calibration parameters may be encoded by the use of resistors of predetermined values, programmable read only memory devices, bar codes, or other suitable encoding instrumentalities. The encoded information is transmitted to a decoder 74 in the system processor 68 .
  • the NIRS assembly detachable connector 91 allows for attachment and removal from the laser box housing 90 .
  • a fiber optic coupler 93 provides an interface for the single core fiber optic 39 of the NIRS transducer assembly and laser box 90 .
  • the shielded cable coupler provides an interface for the photodiode output to the laser box and a second cable coupler 104 provides an interface to the transducer encoded parameters 92 .
  • the automatic power control drivers 64 may be separated into adjustable components 80 , and non adjustable components 82 .
  • the adjustable components 80 are disposed in the connector housing 62 and the non-adjustable components 82 are incorporated into the NIRS system processor 68 .
  • the adjustable components 80 include variable potentiometers, which are used in adjusting the laser power output.
  • the non-adjustable components 82 consist of fixed semiconductor and discrete electronic components, and are typically resistors and capacitors.
  • the connector housing 62 also contains a calibration parameter encoding mechanism 70 which provides the NIRS system processor with necessary information relating the NIRS transducer assembly characteristics, as described previously.
  • a photodiode preamplifier 76 may be located in the connector housing 62 as shown in FIG. 13 for providing amplification of the light level signal from the EMI-shielded laser diode assembly 14 and transmitting the amplified signal to a signal processing and laser safety interlock control portion 78 of the NIRS system processor 68 .
  • FIG. 14 shows an alternative placement of the preamplifier 76 , which can be integrated with, or placed next to, the photodiode 18 inside the transducer assembly 2 .
  • a preamplifier power cable 84 supplies power to the preamplifier 76 .
  • the multi-fiber optic combiner assembly 100 shown in FIG. 13 and FIG. 14 allows for multiple laser light sources of different wavelengths to be coupled into a small diameter core fiber optic output 39 leading to transducer housing 2 .
  • the multi-fiber optic combiner assembly 100 is expanded in FIGS. 15-17 to show more detail.
  • FIG. 15 shows the basic principle of using two ball lenses to focus light from the larger diameter fiber optic bundle 110 into a smaller diameter single core multimode fiber optic 116 .
  • Ball lens 112 refracts and collimates light from input fiber bundle 110 , as shown by light rays 111 .
  • Ball lens 114 focuses the collimated light at, or just outside of, its surface into a small spot onto output fiber 116 , as shown by light rays 113 .
  • Ball lens 114 has a higher refractive index “n” than ball lens 112 so as to focus the light onto a smaller diameter output fiber. Ball lens 114 may also have a smaller spherical diameter to further refract the light to a smaller spot size.
  • the numerical aperture “NA” of the output fiber 116 is greater than or equal to the input fiber bundle 110 , so as to allow maximum coupling of light to the output fiber 116 .
  • FIGS. 16 and 17 show a representative example of a multi-fiber optic combiner assembly 100 .
  • Four individual multimode fiber optics (0.39 NA, 200 ⁇ m core diameter, from 3M Company, St. Paul, Minn.) coupled to four different wavelength laser diodes are bundled together to form an input fiber bundle 110 with an outside diameter of 555 ⁇ m.
  • Output fiber 116 is preferably a single multimode fiber optic with a core diameter of 300 ⁇ m and an overall core/cladding diameter of 325 ⁇ m (0.39 NA, from 3M Company, St. Paul, Minn.).
  • the ball lens 112 can be made of BK7 glass which has a refractive index (n) of 1.52.
  • the spherical diameter of the ball lens 112 is preferably 4 mm, which is trimmed into a drum shape with a diameter on one axis of 3.2 mm.
  • the ball lens 114 preferably has a spherical diameter of 3.2 and is preferably made of sapphire which has a refractive index (n) of 1.77.
  • the laser pigtailed input fiber light coupling efficiency into the output fiber with the ball lens arrangement is about 55 to 60%. Using anti reflective coatings on the ball lenses can further improve the coupling efficiency.
  • the input fiber bundle 110 terminates in a SMA 905 type fiber optic connector 118 and the output fiber optic 116 terminates in a second SMA connector 124 .
  • connector 124 is inserted into SMA coupler assembly consisting of coupler components 120 , 122 , and 126 .
  • the ball lenses having an outside diameter of 3.2 mm slide snugly into the 3.2 mm inside diameter of the SMA coupler assembly, centering the ball lenses to the fiber optic center axis.
  • a hollow spacer 128 is inserted next to ball lens 112 to focus the input fiber bundle 110 light onto output fiber 116 .
  • an adhesive can be used to secure the ball lenses into position.
  • a spacer 128 can be inserted between the ball lens 114 and the output connector 124 for focusing purposes. Finally, an input connector 118 is inserted snugly into the SMA coupler assembly. The advantages of this assembly are that standard components are used, with automatic ball lens centering on the fiber optic light transmission axis, and one-step alignment with the spacer 128 .
  • the NIRS transducer assembly 2 of this invention operates as follows.
  • the assembly 2 has a multiplexed laser diode firing system in which only one laser diode at a time (emitting one wavelength) is pulsed “ON” and is modulated at a predetermined carrier frequency.
  • the automatic power control (APC) drivers 64 for the laser diodes 14 will also operate at the predetermined modulation rate while maintaining the tight power tolerance.
  • the duration of the dark period is usually much longer than the time period when the laser diodes are “ON”. Thus, the overall duty cycle of the laser diodes is small.
  • the photodiode located in the NIRS probe detects the laser light that irradiates the biological tissue.
  • a transimpedance photodiode preamplifier converts the detected light to a voltage.
  • a band pass filter of predetermined bandwidth, centered on the carrier frequency will be the first step in filtering out noise from the detected signal. Demodulation of the detected signal further attenuates noise and removes the carrier frequency.
  • An adjustable gain amplifier will be used to increase the detected light levels to the desired range.
  • An analog-to-digital converter demultiplexes each wavelength, the converter being controlled by timing circuitry that is synchronized with the laser diode pulsing.
  • the data obtained is processed by a computer by use of a multivariate Modified Beer-Lambert Law algorithm which calculates the physiological parameters of interest.
  • the determined physiological parameters: (Hb), (HbO 2 ), and (Total Hb) are displayed on a monitor.
  • the NIRS algorithm employed by the assembly of this invention is based on a multivariate form of the Beer-Lambert Law which is expressed in a matrix form since three laser diodes are employed. Relative changes of the concentrations of HbO 2 and Hb can be quantified by using the modified Beer-Lambert Law, which takes into account the optical attenuation in a highly scattering medium like biological tissue. Absolute measurement of chromophore concentration is very challenging because the determination of optical attenuation due to scattering losses is difficult. However, by measuring differential optical attenuation from an initial baseline, optical attenuation due to scattering is canceled out.
  • the multivariate form of the modified Beer-Lambert Law requires that optical attenuation needs to be measured at least two different wavelengths to determine the two unknown chromophores (HbO 2 and Hb). If the number of wavelengths used is equal to the number of chromophores of interest, then the solution can be solved by Cramer's Rule. If the number of wavelengths used is greater than the number of chromophores of interest, as in the case of the NIRS system described above, a least squares multi linear regression method is used in the algorithm to solve for the chromophores of interest. In theory, the greater the number of measurement wavelengths the more increased reduction of errors in the determination of the chromophore concentration is achieved.
  • the laser intensity utilized will be far below the threshold indicated in ANSIZ 136.1-1993 for cases of accidental eye exposure. This is because of the conical radiation pattern, low duty cycle, and the low power level of the laser light.
  • the incorporation of a laser safety interlock further minimizes the possibility of laser light exposure to personnel using the NIRS system.
  • the safety interlock system inhibits laser diode pulsing immediately if the NIRS assembly is not securely attached to the subject.
  • FIG. 18 shows a flow chart that demonstrates the operation of the laser safety interlock.
  • the laser intensity will be re-measured at time T 1 , and compared to the levels at T 0 .
  • the ratio of intensity change I R will be near the value of 1. If the optical transducer is disturbed or detached, then the detected laser intensity will either increase or decrease from the time prior the disturbance. The detected intensity changes of the lasers due to a disturbed or detached transducer over time period T 1 -T 0 , will be greater than the detected intensity changes of the lasers due to extreme physiological changes such as a drop in tissue oxygenation. Therefore, if I R changes above or below a predetermined range over a predetermined time period T 1 -T 0 , then the lasers will be shut down. Otherwise the lasers will remain active.
  • the ambient light level and laser power will be continually analyzed at the predetermined time period ⁇ T.
  • the sensitivity of the laser safety interlock can be adjusted by selecting the appropriate values for maximum ambient light level allowed, range of laser intensity allowed, allowable change in I R of the lasers over a period of ⁇ T, and/or the period ⁇ T itself.
  • the advantages of this laser interlock scheme are that minimal additional components are needed, and the flowchart can be implemented in software.
  • low laser detected light levels would indicate that the laser light potentially is radiating in free space, or is obstructed.
  • High detected laser light levels would indicate that the assembly is loose, by assuming that laser light is reflecting off the skin or an object to the photodiode 10 , without passing through biological tissue.
  • ambient light is monitoring by measuring the low frequency component (0 to 20 Hz) of the detected light. This is obtained by low pass filtering the photodiode preamplifier output.
  • the ambient light detected reaches a predetermined level, indicating possible NIRS assembly detachment, laser operation is inhibited.
  • the laser diodes 14 will not pulse until the ambient light level is below the set maximum limit, which will initially indicate secure assembly attachment during the beginning of the monitoring session. Any event that indicates assembly detachment will require user intervention to reattach the assembly 2 and to reset the laser safety interlock before laser diode pulsing can resume.
  • This method is an improvement by only analyzing the changes of laser intensity with one light detector, and not the ratio of the laser intensity changes from a reflection detector divided by the laser light intensity changes from an output detector over a predetermined measuring period T 1 -T 0 .
  • Another improvement is that this method provides means to determine if the optical transducer is initially securely attached to the subject, before laser activation, by monitoring ambient light levels first. Then once the lasers are powered, the detected intensities of the lasers are checked to verify that they are in a predetermined range. This provides additional safety means to check to see if the lasers are operating properly and are not radiating at a power and intensity level that is too high or too low at startup or any time during a monitoring session.

Abstract

An infrared spectrometric monitoring transducer includes a shielded cable, a fiber optic light guide, a transducer housing, a light source, and at least one light detector. The light source is mounted in the transducer housing and is operable to produce a light signal along a plurality of discrete wavelengths. The at least one light detector is mounted in the housing and is operable to receive light energy corresponding to the light signal. The at least one light detector is mounted in the transducer housing spaced a distance apart from the light source along a straight line extending the light source and the at least one light detector. The shielded cable and the fiber optic light guide are disposed adjacent the light source and the transducer has an “L” shape formed by the shielded cable and the fiber optic light guide extending outwardly from the transducer housing in a direction substantially perpendicular to the line between the extending the light source and the at least one light detector.

Description

  • This application is a continuation of U.S. patent application Ser. No. 11/384,615 filed Mar. 20, 2006, which is a continuation of U.S. patent application Ser. No. 09/951,221 filed Sep. 14, 2001, which is a continuation in part of U.S. patent application Ser. No. 09/434,142 filed Nov. 4, 1999, which claimed the benefit of the filing dates of U.S. Provisional Patent Application No. 60/123,849, filed Mar. 12, 1999; and 60/151,319 filed Aug. 30, 1999.
  • This invention was made with Government support under the terms of Contract No. 1R43NS39723-01 awarded by the Department of Health and Human Services. The Government has certain rights in the invention.
  • TECHNICAL FIELD
  • This invention relates to an improvement in a non-invasive near-infrared spectrophotometric (NIRS) optical transducer assembly, and a method of using the same. More particularly, this invention relates to a practical NIRS optical transducer assembly which can be reusable, is safe to use, and which can provide an accurately sized and consistent laser light field on a subject's skin.
  • BACKGROUND ART
  • Near-infrared spectroscopy (NIRS) is an optical spectrophotometric method of continually monitoring tissue oxygenation. The NIRS method is based on the principle that light in the near-infrared range (700 to 1,000 nm) can pass easily through skin, bone and other tissues but, within these wavelengths, hemoglobin has specific absorption spectra, dependent upon its oxidation state, i.e., oxygenated-hemoglobin (HbO2); and deoxygenated-hemoglobin (Hb). By using light sources that transmit near-infrared light at specific different wavelengths, and measuring changes in transmitted or reflected light attenuation, oxygenation concentration changes of HbO2 and Hb can be monitored.
  • Total hemoglobin is the summation of the two states of hemoglobin (Total Hb=HbO2+Hb), and is proportional to relative blood volume changes, provided that the hematocrit or hemoglobin concentration of the blood is unchanged. The most valuable aspect of NIRS is that it allows one to continually monitor cerebral oxygenation levels in an adult or neonate, especially in diseased conditions, in which oxygenation levels in the brain can be compromised, leading to brain damage or death.
  • It is known that near-infrared light passes through the skin and the skull of a neonate readily, and is absorbed by certain biological molecules in the brain. Near-infrared spectroscopy (NIRS) detects oxygenation changes in biological tissue (brain, muscle, or other organs) mainly at the micro circulation level (capillaries, arterioles, and venuoles) based on different absorption characteristics of the chromophores oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) in the near-infrared spectrum (700-1,000 nm). Average tissue penetration is 2-3 cm with sub-second time resolution.
  • Another spectrophotometric method, called pulse oximetry, determines arterial oxygen saturation (SaO2) of peripheral tissue (i.e. finger, ear, nose) by monitoring pulsatile optical attenuation changes of detected light induced by pulsatile arterial blood volume changes in the arteriolar vascular system. The method of pulse oximetry requires pulsatile blood volume changes in order to make a measurement. Since venous blood is not pulsatile, pulse oximetry cannot provide any information about venous blood. Conversely, NIRS does not require pulsatile blood volume to calculate parameters of clinical value.
  • Relative changes of the concentrations of HbO2 and Hb can be quantified by using the modified Beer-Lambert Law, which takes into account the optical attenuation in a highly scattering medium like biological tissue. The modified Beer-Lambert Law can be expressed as:
    A=−log(I/I 0)L=(åL ×C×d×B)+G   (Equation 1);
  • wherein A is the optical attenuation in tissue at wavelength L (units: optical density OD); I0 is the incident light intensity (units: Wlcm2); I is the detected light intensity; (L is the wavelength-dependent absorption coefficient of the chromophore (units: OD×cm−1×μM−1); C is the concentration of chromophore (units: μM); d is the light source-to-detector distance (units: cm); B is the light scattering differential path length factor (unitless); and G is a factor relating to tissue geometry and scattering of light (units: OD).
  • Absolute measurement of chromophore concentration is very difficult because G is unknown. However, over a reasonable measuring period of several hours to days, G remains constant, allowing for the measurement of relative changes of chromophore from a zero reference baseline. Thus, if time t2 is an arbitrary time after the start of the optical measurement at t1 (baseline), differential attenuation ( A) can be calculated, canceling out the variables G and I0, providing that they remain constant. The objective is to determine changes in chromophore concentration [ΔC═C(t2)−C(t1)] from A derived from the equation:
    ΔA=−log(I 2 /I 1)LL =ΔC×d×B   (Equation 2);
  • NIRS algorithms that are designed to calculate the relative changes of more than one chromophore use the multivariate form of Equation 2. To distinguish between, and to compute relative changes in, oxyhemoglobin (ΔHbO2) and in deoxyhemoglobin (ΔHb), a minimum of two different wavelengths, preferably from narrow spectral bandwidth light sources, like laser diodes, are preferred. The units of ΔHbO2 and ΔHb are in (moles per liter of tissue (μM) which is determined from a dimensional analysis of Equation 1.
  • It would be desirable to have a reusable NIRS transducer assembly having the ability to accurately control the energy level and size of a laser light field cast upon a subject's skin as well as improving the light detector signal-to-noise ratio by employing an improved EMI shielding scheme during use of the assembly. It would be desirable to combine light from multiple light sources into a single output fiber optic that is lightweight, and flexible, while providing sufficient light coupling efficiency. It would be desirable to have a transducer dislodgement-laser safety interlock system that would require no extra light source or detector components, while having the ability to disable laser operation due to transducer attachment failure and laser operation failure as well as a scheme that will verify secure transducer attachment before laser activation.
  • DISCLOSURE OF THE INVENTION
  • This invention relates to an improved transducer assembly for use in near-infrared spectroscopy (NIRS) of human patients. A prism providing a laser light source directing means, and one or more photodiodes are contained in a flexible housing which can be easily and securely attached to a subject's head, or some other part of the body. A rigid light guide placed over the prism provides a constant light intensity output of the spectrophotometric measuring system during a measuring period, by maintaining a constant laser light source to skin distance. A light detection means, by utilizing one or more photodiodes, allows for detection of laser light at a predetermined distance(s) away from the light source. The detection of light is improved by implementing an EMI shielding scheme that allows for attenuation of EMI interference while preserving an optical pathway for light to reach the detector via an EMI shielded optically transparent rigid window. An improved method of combining light from multiple light sources into a single output fiber optic that is lightweight, and flexible, while providing sufficient light coupling efficiency for a spectrophotometric measuring system is disclosed. An improved transducer dislodgement-laser safety interlock system is disclosed which does not require extra light source or detector components, while having the ability to disable laser operation due to transducer attachment failure and laser operation failure as well as verifying secure transducer attachment before laser activation.
  • The NIRS transducer assembly of this invention may consist of two separable components, the NIRS transducer housing containing the laser light source and photodiode(s) described above; and a disposable adhesive envelope or pad which is used to mount the NIRS transducer assembly housing easily and securely to the subject's skin. It is economically more feasible to use a non-disposable NIRS transducer housing with a disposable envelope rather than a disposable NIRS transducer housing, while maintaining all of the advantages of single use, disposable transducer applications, especially in a health care environment, in which sanitation and sterilization requirements are paramount.
  • The advantage of using a light radiation with a narrow spectral bandwidth (<1-3 nm) is maintained.
  • The rigid laser light guide, which is placed over the output window of the laser light redirecting prism, has several functions. One function is to further decrease the intensity of laser light on the skin of a subject undergoing spectrophotometric monitoring by taking advantage of the conical radiation characteristics of the laser diode coupled to a optical light guide such as a multimode or single mode fiber optic. Thus, with an increasing separation distance (r) between the laser diode fiber optic output and the skin surface, the intensity (power/area) of the laser light decreases by a factor of r2. The prism, which redirects the laser-fiber optic output provides most of the separation distance from the light source to skin. The use of the laser light guide increases the separation distance and thus further decreases light intensity on the skin. This is important for designing a laser light source based optical transducer assembly meant to be directly applied to a human forehead, or some other part of the human body. To assure safety for the skin and tissue, the laser diode optical transducer assembly must be designed to operate within the limitations which are imposed by the “Maximum Permissible Exposure” (MPE) values set forth by the American National Standard for the safe use of lasers (ANZ136.1-1993).
  • The laser light guide is rigid and provides a planar interface between the assembly and the patients skin in which the laser light is illuminating. The light guide controls the spacing between the prism and the subject's skin, and therefore controls the incident light intensity I0 (from Equation 1) on the subject's skin. This is especially important when attempting to measure absolute chromophore values as determined from Equation 1.
  • One or more photodiodes are also incorporated in the NIRS transducer assembly housing, separated from the laser diodes light source by from a few mm to more than about 60 mm, depending on the size of the subject being monitored. For a typical adult human head, it is believed that at least 45 mm separation distance is needed for adequate brain blood oxygenation monitoring, using a reflection mode type of the NIRS transducer assembly. Multiple photodiodes can be used to monitor different depths of blood oxygenation in the subject, or can be used as reference detectors for algorithms that compensate for the scalp component of the detected signals. For neonates, shorter separation distances between the laser diodes and the photodiodes of around 20 mm can be used for reflection mode monitoring, or large distances over 60 mm can be used for trans-cranial mode NIRS transducer assembly. Photodiodes with larger surface areas can be used as the laser light source-to-photodiode separation distances increase to compensate for the decreasing light levels detected from larger separation distances or lower power light sources.
  • A photodiode preamplifier, placed next to the photodiode, or farther away as a separate assembly, allows for amplification of the detected low light level signal, and then provides the amplified signal to the NIRS system processor.
  • A partially optically transparent, and electrically conductive shield which surrounds the photodiode can be used to attenuate ambient electromagnetic interference (EMI) noise which is otherwise transmitted to the photodiode. A window in the shield exposes the photodiode's photosensitive surface to detected light from the laser diodes. The optically transparent electrically conductive shield may include a thin metal wire screen, an electrically conductive transparent coating, or the like. By placing an optically transparent rigid spacer over the photodiode light sensitive surface, further EMI attenuation can be achieved by reducing the capacitive coupling between the subject's skin and the photodiode photosensitive surface.
  • The use of a disposable adhesive envelope or pad for the purpose of securing the NIRS transducer assembly housing to the subject's skin renders the transducer assembly housing reusable from subject to subject. The disposable adhesive envelope or pad can be pre-sterilized thereby providing additional protection to the subject. The disposable envelope or pad will also protect the NIRS transducer assembly housing from any residue from the subject, allowing the NIRS probe housing surface to remain uncontaminated, thus making it safer and easier to reuse.
  • Different NIRS transducer assemblies are designed to be interchangeable with different NIRS system processors/monitors by incorporation of custom laser diode drivers and encoded calibration parameters in a connector housing. The NIRS system processor has an interface port for the connector housing. The connector housing may contain customized laser diode automatic power control (APC) drivers, which are individually adjusted to provide a predetermined laser diode output power. By providing encoded calibration parameters in the connector housing, the NIRS system processor can determine the characteristics of each individual NIRS transducer and laser diode characteristics by a decoding mechanism, calibrating the NIRS algorithm to provide accurate computation with different transducer assemblies and individual laser diode characteristics.
  • To minimize complexity of the NIRS transducer assembly, a single core multimode fiber optic is used as a light guide to transfer laser light from a detachable connector to the prism inside the transducer housing. A multi-fiber optic combiner assembly channels light from multiple laser light sources into a single fiber optic by utilizing two ball lenses of predetermined characteristics. The advantage of using a ball lens multi-fiber optic combiner is that a smaller diameter single core multimode output fiber optic can be used. Use of a smaller core fiber optic in the cable interfacing the NIRS transducer housing to the detachable connector, reduces weight, increases flexibility, and reduces induced torque from bending.
  • The incorporation of several laser safety interlock schemes further minimizes the possibility of unnecessary laser light exposure to personnel using the optical transducer. The safety interlock system inhibits laser diode pulsing immediately if the optical transducer is not securely attached to the subject. The three interlock schemes include: 1) monitoring ambient light conditions; 2) monitoring laser output range; and 3) monitoring sudden changes in detected laser output over a period of time.
  • When the optical transducer is attached properly to the subject's forehead in normal daytime operation, the detected ambient light level is low because the probe body shields outside light. When the detected ambient light reaches a predetermined level, indicating possible transducer detachment or improper placement, laser operation is inhibited. Accidental probe detachment will automatically shut down the laser diodes.
  • For night-time operation of the NIRS system, additional interlock systems are employed. The light detector in the optical transducer continuously monitors the laser diode output. If the detected laser signal falls out of a predetermined range, then immediate laser shutdown occurs. Also, if the detected laser signal suddenly changes a predetermined amount over a predetermined time period due to probe disruption or detachment, immediate laser shutdown will occur. Any event that indicates probe detachment will require user intervention to re-attach the probe and to reset the NIRS system laser safety interlock before laser diode pulsing can resume.
  • Enabling but non-essential details of the invention will become more readily apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings in which:
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a plan view of one embodiment of a reflective NIRS transducer assembly which is formed in accordance with this invention;
  • FIG. 2 is a side sectional view of the transducer assembly of FIG. 1;
  • FIG. 3 is a view of the light source portion of the embodiment of FIG. 2;
  • FIG. 4 is an enlarged sectional view showing the relationship between the transducer assembly fiber optic laser light source, prism, and rigid light guide with the subject's skin;
  • FIG. 5 is an enlarged sectional view of the photodiode portion of the transducer assembly of FIG. 2 showing details of the wire mesh type EMI shielding mechanisms for the photodiodes;
  • FIG. 5A is an enlarged sectional view of the photodiode portion of the transducer assembly of FIG. 2 showing details of the electrically conductive thin film type EMI shielding mechanisms for the photodiodes;
  • FIG. 6 is an enlarged plan view of the EMI shielded photodiode portion of the transducer assembly of FIG. 2;
  • FIG. 7 is an enlarged sectional view of an alternative photodiode packaging showing details of the EMI shielding mechanisms;
  • FIG. 8 is an enlarged sectional view of the photodiode with preamplifier amplifier showing details of the EMI shielding mechanisms employed;
  • FIG. 9 is a plan view of a disposable self-adhesive envelope which is designed for use in containing the transducer assembly housing of FIG. 1;
  • FIG. 10 is a plan view of a disposable self-adhesive pad which is designed for use in connection with the transducer assembly housing of FIG. 1;
  • FIG. 11 is a plan view of another embodiment of a reflective NIRS transducer, in which the fiber optic and shielded cable leads exit at an angle of 90° from the configuration shown in FIG. 1 to form an “L”-shaped housing.
  • FIG. 11A shows how the “L”-shaped NIRS transducer of FIG. 11 is attached to a neonate's head.
  • FIG. 12 is a plan view of another embodiment of a transmissive NIRS transducer assembly which is formed in accordance with this invention;
  • FIG. 13 is a schematic view of a NIRS transducer assembly formed in accordance with this invention which is associated with a connector housing, laser box assembly, encoding and decoding means of calibration parameters, and a NIRS system processor;
  • FIG. 14 is schematic view of a NIRS transducer assembly which is similar to FIG. 13, but showing partitioned laser power control drivers and the pre-amp portion of the system located in the assembly housing;
  • FIG. 15 is a light ray diagram of the multi-fiber optic light combiner assembly;
  • FIG. 16 shows the details of the multi-fiber optic light combiner assembly;
  • FIG. 17 shows details of the assembly process of the multi-fiber optic light combiner; and
  • FIG. 18 shows the details of the employed laser safety interlock scheme displayed in flowchart form during normal operation of the NIRS transducer/monitor system processor.
  • DETAILED DESCRIPTION THE INVENTION
  • Referring now to the drawings, there is shown in FIGS. 1 and 2 an embodiment of a reflective-type NIRS transducer assembly which is denoted generally by the numeral 2. The transducer assembly 2 includes a housing 4 which contains the components of the transducer assembly 2. The housing 4 includes a flexible light-shielding surface rubber layer 6 having a first window 8 allowing light to reach the EMI shielded photodiode assembly 18 which is disposed in the housing 4. The surface layer 6 is made of a durable material to allow attachment and removal of a disposal adhesive attachment method. A laser light guide 28 is overlying and optically coupled to the prism 30, which protrudes slightly from surface layer 6. The sides of photodiode window 8 and light guide 28 perpendicular to surface layer 6 are painted with a light-shielding material to prevent optical shunting, i.e., light from entering through the sides of the windows. In an alternative embodiment, the surface of window 8 and light guide 28 are flush with the exposed surface of surface layer 6. Fiber optics 39 direct light from remotely located laser diodes to the prism 30 and are secured in place by the fiber optic mount 27. The housing 4 also includes a flexible, electrically and optically insulating body 24 which can be formed from rubber or some other suitable elastomer, attached to a flexible support structure 26. The light source assembly 20, the EMI-shielded photodiode assembly 18, and surface layer 6 are also mounted on the flexible support structure 26. Another shielded cable 38 interconnects the photodiode assembly 18 and the NIRS system processor assembly via an interface connector housing (See FIG. 13). The NIRS system processor analyzes the results of the NIRS reflectance data gathered by the photodiode 10.
  • Referring now to FIG. 3, details of the light source assembly 20 is shown. The light redirecting prism 30 is connected to the rigid light guide 28 which provides surface-to-surface contact between the prism 30 and the subject's skin S. The light guide 28 is rigid so that when it is pressed against the subject's skin during the monitoring of blood oxygen, the surface S of the skin is flattened, and the distance between the fiber optic 39 output and the skin surface S via the prism 30 is constant across the entire illuminated area of the skin.
  • Shown in FIG. 4 are the arrangements of the light guide 28 and prism 30 demonstrating how the distance “r” between the laser coupled fiber optic 39 output and the surface S of the subject's skin can be controlled. First of all, it is noted that the planar surface S′ of the light guide 28, when pressed against the subject's skin S, will flatten the contacted area of the subject's skin S so that the distance “r” between the laser coupled fiber optic 39 and the subject's skin S is constant for the entire skin area which is illuminated by the light guide 28. The inclusion of the light guide 28 with the prism 30 results in the effective length of “r” since r r1+r2+r3. Thus, with the light guide plus prism arrangement, one can effectively reduce the light intensity of the laser coupled fiber optic 39 output field which is delivered to the subject's skin S. If further attenuation means of the laser light field imposed on the skin S′ is desired, then the light guide 28 may include a selective filter 29. The selective filter 29 may consist of a light-attenuating neutral density filtering element, or a light-diffusive element, such as a milky white semi-transparent plastic material, or both, in combination.
  • FIGS. 5, 5A, and 6 illustrate an ambient EMI shielding arrangement for the photodiode detector window 8. An EMI shielded and optically transparent pane 32 of predetermined thickness, is positioned over the light sensitive surface 34 of the photodiode detector 10. The photodiode detector 10 includes a light-sensitive element 9 which is disposed in a ceramic cup 11. A wire mesh 36 is embedded between two optically transparent members 31 and 33, which form the pane 32. The mesh 36 will allow at least about 60% optical transmission of the reflected light from the laser light source 20 after passage through biological tissue to reach the photodiode 10. A non-porous EMI shield 37, such as an electro-conductive metal foil, surrounds the non-light sensitive parts of the housing, including the photodiode lead 23. An electrically conductive gasket 40, such as silicone paste, adhesive, foam, or other similar material, is used to create an electrical interface between the wire mesh 36 of the EMI shielded pane 32 and the non-porous EMI shield 37.
  • In an alternative EMI shielding embodiment, the wire mesh 36 could be placed directly over the photodiode light sensitive surface 34, and an optically transparent, electrically insulating pane 32 having a predetermined thickness, formed from a material such as glass, could then be placed over the wire mesh 36.
  • FIG. 5A shows an alternative embodiment in which the wire mesh 36 and lower optical member 33 are replaced with a thin optical member 48 that is coated with an electrically conductive, optically transparent thin film on one side. The electrically conductive film of thin optical member 48 is electrically interfaced to the non-porous EMI shield 37 by electrically conductive epoxy, adhesive, paste, or the like. In an alternative embodiment, the optical member 31 may be coated with an electrically conductive, optically transparent thin film on the side facing the photodiode 10.
  • FIG. 7 shows how a photodiode packaged in the “can” style package 45 can be EMI shielded by applying a wire mesh or thin film EMI shield 41 over the photodiode package “can” aperture. An electrically insulating, optically transparent window 43 would then cover the EMI shield 41.
  • FIG. 8 shows a preamplifier 76 placed next to photodiode 10, and enclosed in the EMI shielding structures similar to those described in FIG. 5 through FIG. 7.
  • These shielding structures reduce undesirable EMI generated noise, and improve the signal to noise ratio of the photodiode by two different methods. The wire mesh 36 or electrically conductive film 48 in combination with the non-porous electro-conductive material 37 creates a Faraday Cage around the photodiode 10, while allowing light to reach the photodiode 10 light-sensitive surface 34. By using an EMI attenuating optically transparent pane 32 of a predetermined thickness, preferably of about 1 mm or greater, further EMI attenuation is attained by increasing the photodiode-to-biological tissue separation distance. This optically transparent spacer reduces the capacitance between the photodiode light sensitive surface 34 and the biological tissue, such as human skin, resulting in the increased reduction in electromagnetic coupling and generated noise currents when compared to using the Faraday Cage shielding method without the optical spacer.
  • To construct the EMI shielded optical sensor, commercially available EMI shielded wire mesh windows from Chomerics (Woburn, Mass.) can be used. Chomerics “EMI CLARE”™ GP 70 EMI shielded windows provide 60 to 70% light transmission, with different pane thicknesses of 1.66 mm; 2.00 mm; and 3.00 mm being available. The transparent panes 32 and the mesh 36 need to be sized to close the window 8 and cover the light-sensitive surface 34 of the photodiode 10, which surface 34 can range in size from four square mm to one hundred square mm. Alternatively, Chomerics “WIN-SHIELD”™ AgF8 conductive film can be used in place of the wire mesh window. This conductive film is 0.2 mm thick and has similar optical properties as the mesh window. In another embodiment, a copper mesh wire cloth like material from Sefar America, Inc. (Briarcliff Manor, N.Y.) can be used as an EMI shield over the photodiode photosensitive surface.
  • Referring now to FIGS. 9 and 10, there are shown two different types of discardable or disposable adjunct adherence devices that can be used in conjunction with the transducer assembly 2. FIG. 9 shows an envelope 42 which can be used to house the assembly 2. The envelope 42 has two transparent plastic windows or open apertures 44 and 46 which are sized and positioned to be in registry with light source assembly 20, and with the photodiode assembly 18, respectively. The transducer assembly 2 is inserted into the envelope 42 through an opening 48. The transparent window version of envelope 42 is used if the rigid laser light guide 28 and photodiode window 32 are flush with upper surface layer 6. The open aperture window version of envelope 42 is used if the rigid laser light guide 28 and photodiode window 32 protrude slightly from the upper surface layer 6 as shown in FIG. 1, with the respected windows locking into place. The envelope 42 also includes several clasps 50 that are used to secure the assembly 2 in place in the envelope 42. The surface 52 of the envelope 42 is formed from, or coated with, an adhesive material. The envelope 42 is preferably formed from a light-impermeable material such as rubber or black plastic. This prevents light from directly traveling between the laser diodes and the photodiode (i.e., no optical shunting) which could occur with a transparent envelope.
  • FIG. 10 shows a disposable or discardable adhesive pad 54 which can be releasably adhered to the transducer assembly 2 and to the subject's skin. The pad 54 is preferably formed from rubber or black plastic, and includes opposed adherent surfaces such as 60 which enable the pad 54 to be adhered to the transducer assembly 2 and to the subject's skin S. The pad 54 has two transparent plastic windows or open apertures 56 and 58 which are sized and positioned to be in registry with the light source assembly 20, and with the EMI shielded photodiode assembly 18, respectively. The transparent window version of pad 54 is used if the rigid laser light guide 28 and photodiode window 32 are flush with upper surface layer 6. The open aperture window version of pad 54 is used if the rigid laser light guide 28 and photodiode window 32 protrude slightly from the upper surface layer 6 as shown in FIG. 1, with the respective windows fitting through their respective open apertures. The envelope 42 and the pad 54 are both sterile prior to use, and can be discarded after being removed from the patient.
  • FIG. 11 shows an alternative embodiment of the NIRS transducer assembly of FIG. 1 in which the fiber optic light guide 39 and shielded cable 38 exit the transducer housing 4 on the side, giving the probe assembly an “L” shape. A support appendage 21 further secures the fiber optics 39 and cable 38 to the transducer housing 4. Recessed cutouts 7 in the housing 4 as shown allow for added flexibility of the optical transducer 2 when applied to curved surfaces such as the head or body appendage. This “L”-shaped NIRS optical transducer is especially useful for brain oxygenation monitoring on awake neonates and awake adults by allowing the fiber optics 39 and cable 38 to come off the subject over the crown of the head (see FIG. 11A) as opposed to the side of the subject's head when the transducer assembly is placed on the forehead. The fiber optics 39 and cable 38 are out of grasping range of a neonate's hand, reducing possible transducer disturbance. Also, the transducer is less likely to be disturbed when the neonate sleeps on his or her side, which may result in the neonate sleeping on the NIRS transducer fiber optic-shielded cable leads.
  • FIG. 12 shows an embodiment of a NIRS transducer assembly formed in accordance with this invention which is suitable for use with neonates. In this embodiment, the EMI shielded photodiode assembly 18 is contained on one shielded pod 13, and the light source assembly 20 is contained in another pod 15. The pods 13 and 15 are connected by the cable 38, and the fiber optic cable 39 extends from the pod 15 to the controller. The length of the cable 38 is sufficient to allow the pods 13 and 15 to be attached to opposite sides of the neonate's head to allow the monitoring of cerebral blood oxygenation.
  • FIG. 13 illustrates the components of a NIRS transducer assembly connector housing 62 which enables interchangeability of the laser diodes and other components. The laser box housing 90 contains laser diode automatic power control drivers 64 which interface with the laser diodes 14. A laser diode sequencer control 66 forms a portion of the NIRS system processor 68 and provides multiplexed pulsing of the laser diodes 14. Each laser diode power output is adjusted by its respective automatic power control driver. There are three different laser diode pin-out configurations available, each of which requires different types of automatic power control drivers. Thus, incorporation of the automatic power control drivers 64 in the laser box housing 90 provides flexibility in the selection of the laser diodes 14.
  • The laser box housing 90 also contains a calibration parameter encoding mechanism 70, along with NIRS transducer encoded parameter mechanism 92, which provides the NIRS system processor with necessary information relating the laser box housing and NIRS transducer assembly characteristics. The calibration parameters include: laser diode wavelength; coefficients relating to the change in laser diode wavelength over temperature changes; laser diode automatic power control feedback monitor current and corresponding laser power output; transducer light source to photodiode separation distance; encoding coefficients indicating the type of NIRS transducer specifically intended to be used on a certain type of biological tissue, subject body part, or certain subject species; and other information as needed about the characteristics of the individual NIRS transducer assembly being employed. The calibration parameters may be encoded by the use of resistors of predetermined values, programmable read only memory devices, bar codes, or other suitable encoding instrumentalities. The encoded information is transmitted to a decoder 74 in the system processor 68.
  • The NIRS assembly detachable connector 91 allows for attachment and removal from the laser box housing 90. A fiber optic coupler 93 provides an interface for the single core fiber optic 39 of the NIRS transducer assembly and laser box 90. Similarly, the shielded cable coupler provides an interface for the photodiode output to the laser box and a second cable coupler 104 provides an interface to the transducer encoded parameters 92.
  • In an alternative connector assembly embodiment shown in FIG. 14, the automatic power control drivers 64 may be separated into adjustable components 80, and non adjustable components 82. In this embodiment, the adjustable components 80 are disposed in the connector housing 62 and the non-adjustable components 82 are incorporated into the NIRS system processor 68. The adjustable components 80 include variable potentiometers, which are used in adjusting the laser power output. The non-adjustable components 82 consist of fixed semiconductor and discrete electronic components, and are typically resistors and capacitors. The connector housing 62 also contains a calibration parameter encoding mechanism 70 which provides the NIRS system processor with necessary information relating the NIRS transducer assembly characteristics, as described previously.
  • A photodiode preamplifier 76 may be located in the connector housing 62 as shown in FIG. 13 for providing amplification of the light level signal from the EMI-shielded laser diode assembly 14 and transmitting the amplified signal to a signal processing and laser safety interlock control portion 78 of the NIRS system processor 68. FIG. 14 shows an alternative placement of the preamplifier 76, which can be integrated with, or placed next to, the photodiode 18 inside the transducer assembly 2. A preamplifier power cable 84 supplies power to the preamplifier 76.
  • The multi-fiber optic combiner assembly 100 shown in FIG. 13 and FIG. 14 allows for multiple laser light sources of different wavelengths to be coupled into a small diameter core fiber optic output 39 leading to transducer housing 2. The multi-fiber optic combiner assembly 100 is expanded in FIGS. 15-17 to show more detail. FIG. 15 shows the basic principle of using two ball lenses to focus light from the larger diameter fiber optic bundle 110 into a smaller diameter single core multimode fiber optic 116. Ball lens 112 refracts and collimates light from input fiber bundle 110, as shown by light rays 111. Ball lens 114 focuses the collimated light at, or just outside of, its surface into a small spot onto output fiber 116, as shown by light rays 113. Ball lens 114 has a higher refractive index “n” than ball lens 112 so as to focus the light onto a smaller diameter output fiber. Ball lens 114 may also have a smaller spherical diameter to further refract the light to a smaller spot size. The numerical aperture “NA” of the output fiber 116 is greater than or equal to the input fiber bundle 110, so as to allow maximum coupling of light to the output fiber 116.
  • FIGS. 16 and 17 show a representative example of a multi-fiber optic combiner assembly 100. Four individual multimode fiber optics (0.39 NA, 200 μm core diameter, from 3M Company, St. Paul, Minn.) coupled to four different wavelength laser diodes are bundled together to form an input fiber bundle 110 with an outside diameter of 555 μm. Output fiber 116 is preferably a single multimode fiber optic with a core diameter of 300 μm and an overall core/cladding diameter of 325 μm (0.39 NA, from 3M Company, St. Paul, Minn.). The ball lens 112 can be made of BK7 glass which has a refractive index (n) of 1.52. The spherical diameter of the ball lens 112 is preferably 4 mm, which is trimmed into a drum shape with a diameter on one axis of 3.2 mm. The ball lens 114 preferably has a spherical diameter of 3.2 and is preferably made of sapphire which has a refractive index (n) of 1.77. The laser pigtailed input fiber light coupling efficiency into the output fiber with the ball lens arrangement is about 55 to 60%. Using anti reflective coatings on the ball lenses can further improve the coupling efficiency.
  • The input fiber bundle 110 terminates in a SMA 905 type fiber optic connector 118 and the output fiber optic 116 terminates in a second SMA connector 124. To assemble together, connector 124 is inserted into SMA coupler assembly consisting of coupler components 120, 122, and 126. The ball lenses, having an outside diameter of 3.2 mm slide snugly into the 3.2 mm inside diameter of the SMA coupler assembly, centering the ball lenses to the fiber optic center axis. A hollow spacer 128 is inserted next to ball lens 112 to focus the input fiber bundle 110 light onto output fiber 116. Alternatively, an adhesive can be used to secure the ball lenses into position. In an alternative embodiment, a spacer 128 can be inserted between the ball lens 114 and the output connector 124 for focusing purposes. Finally, an input connector 118 is inserted snugly into the SMA coupler assembly. The advantages of this assembly are that standard components are used, with automatic ball lens centering on the fiber optic light transmission axis, and one-step alignment with the spacer 128.
  • The NIRS transducer assembly 2 of this invention operates as follows. The assembly 2 has a multiplexed laser diode firing system in which only one laser diode at a time (emitting one wavelength) is pulsed “ON” and is modulated at a predetermined carrier frequency. The automatic power control (APC) drivers 64 for the laser diodes 14 will also operate at the predetermined modulation rate while maintaining the tight power tolerance. There is a dark period in which all of the laser diodes 14 will be “OFF”, allowing for offset voltages to be sampled and subtracted. The duration of the dark period is usually much longer than the time period when the laser diodes are “ON”. Thus, the overall duty cycle of the laser diodes is small. The photodiode located in the NIRS probe detects the laser light that irradiates the biological tissue. A transimpedance photodiode preamplifier converts the detected light to a voltage. A band pass filter of predetermined bandwidth, centered on the carrier frequency will be the first step in filtering out noise from the detected signal. Demodulation of the detected signal further attenuates noise and removes the carrier frequency. An adjustable gain amplifier will be used to increase the detected light levels to the desired range. An analog-to-digital converter demultiplexes each wavelength, the converter being controlled by timing circuitry that is synchronized with the laser diode pulsing. The data obtained is processed by a computer by use of a multivariate Modified Beer-Lambert Law algorithm which calculates the physiological parameters of interest. The determined physiological parameters: (Hb), (HbO2), and (Total Hb) are displayed on a monitor.
  • The NIRS algorithm employed by the assembly of this invention is based on a multivariate form of the Beer-Lambert Law which is expressed in a matrix form since three laser diodes are employed. Relative changes of the concentrations of HbO2 and Hb can be quantified by using the modified Beer-Lambert Law, which takes into account the optical attenuation in a highly scattering medium like biological tissue. Absolute measurement of chromophore concentration is very challenging because the determination of optical attenuation due to scattering losses is difficult. However, by measuring differential optical attenuation from an initial baseline, optical attenuation due to scattering is canceled out. The multivariate form of the modified Beer-Lambert Law requires that optical attenuation needs to be measured at least two different wavelengths to determine the two unknown chromophores (HbO2 and Hb). If the number of wavelengths used is equal to the number of chromophores of interest, then the solution can be solved by Cramer's Rule. If the number of wavelengths used is greater than the number of chromophores of interest, as in the case of the NIRS system described above, a least squares multi linear regression method is used in the algorithm to solve for the chromophores of interest. In theory, the greater the number of measurement wavelengths the more increased reduction of errors in the determination of the chromophore concentration is achieved. Thus, the use of three laser diodes to measure two chromophores, as described above, will result in a more accurate measurement of the two chromophores. It will be appreciated that the system described above could also be modified to measure a third chromophore in biological tissue, such as cytochrome.
  • The laser intensity utilized will be far below the threshold indicated in ANSIZ 136.1-1993 for cases of accidental eye exposure. This is because of the conical radiation pattern, low duty cycle, and the low power level of the laser light. The incorporation of a laser safety interlock further minimizes the possibility of laser light exposure to personnel using the NIRS system. The safety interlock system inhibits laser diode pulsing immediately if the NIRS assembly is not securely attached to the subject.
  • FIG. 18 shows a flow chart that demonstrates the operation of the laser safety interlock. When the NIRS optical transducer is secured to the patient, the user will turn the lasers “ON”. Before the lasers are allowed to activate, the detected ambient light is analyzed to determine if the ambient level is above or below a predetermined limit. If above the limit, then the lasers will be inhibited from operating. Otherwise, the lasers will be allowed to power up. When the lasers are at full power, the detected laser light level determined from the receiver photodiode 10 after propagation through biological tissue will be analyzed. If any of the lasers are above or below a predetermined range, then all the lasers will be shut down. Otherwise the lasers will remain active.
  • At a predetermined time after the detected laser intensity is initially measured at time T0, the laser intensity will be re-measured at time T1, and compared to the levels at T0. For each laser, the detected intensity at T1 will be divided by the intensity at T0:
    Ratio of intensity change (I R)=Laser n (T 1)/Laser n (T 0)
  • Normally the ratio of intensity change IR will be near the value of 1. If the optical transducer is disturbed or detached, then the detected laser intensity will either increase or decrease from the time prior the disturbance. The detected intensity changes of the lasers due to a disturbed or detached transducer over time period T1-T0, will be greater than the detected intensity changes of the lasers due to extreme physiological changes such as a drop in tissue oxygenation. Therefore, if IR changes above or below a predetermined range over a predetermined time period T1-T0, then the lasers will be shut down. Otherwise the lasers will remain active.
  • As shown by the laser interlock flowchart, the ambient light level and laser power will be continually analyzed at the predetermined time period ΔT. The sensitivity of the laser safety interlock can be adjusted by selecting the appropriate values for maximum ambient light level allowed, range of laser intensity allowed, allowable change in IR of the lasers over a period of ΔT, and/or the period ΔT itself. The advantages of this laser interlock scheme are that minimal additional components are needed, and the flowchart can be implemented in software.
  • During optical transducer operation, low laser detected light levels would indicate that the laser light potentially is radiating in free space, or is obstructed. High detected laser light levels would indicate that the assembly is loose, by assuming that laser light is reflecting off the skin or an object to the photodiode 10, without passing through biological tissue.
  • For normal, daytime operation, ambient light is monitoring by measuring the low frequency component (0 to 20 Hz) of the detected light. This is obtained by low pass filtering the photodiode preamplifier output. When the ambient light detected reaches a predetermined level, indicating possible NIRS assembly detachment, laser operation is inhibited. The laser diodes 14 will not pulse until the ambient light level is below the set maximum limit, which will initially indicate secure assembly attachment during the beginning of the monitoring session. Any event that indicates assembly detachment will require user intervention to reattach the assembly 2 and to reset the laser safety interlock before laser diode pulsing can resume.
  • This method is an improvement by only analyzing the changes of laser intensity with one light detector, and not the ratio of the laser intensity changes from a reflection detector divided by the laser light intensity changes from an output detector over a predetermined measuring period T1-T0. Another improvement is that this method provides means to determine if the optical transducer is initially securely attached to the subject, before laser activation, by monitoring ambient light levels first. Then once the lasers are powered, the detected intensities of the lasers are checked to verify that they are in a predetermined range. This provides additional safety means to check to see if the lasers are operating properly and are not radiating at a power and intensity level that is too high or too low at startup or any time during a monitoring session.
  • Since many changes and variations of the disclosed embodiment of the invention may be made without departing from the inventive concept, it is not intended to limit the invention otherwise than as required by the appended claims.

Claims (5)

1. An infrared spectrometric monitoring transducer, comprising:
a shielded cable;
a fiber optic light guide;
a transducer housing;
a light source operable to produce a light signal along a plurality of discrete wavelengths, mounted in the transducer housing;
at least one light detector operable to receive light energy corresponding to the light signal, mounted in the transducer housing spaced a distance apart from the light source along a straight line extending the light source and the at least one light detector;
wherein the shielded cable and the fiber optic light guide are disposed adjacent the light source and the transducer has an “L” shape formed by the shielded cable and the fiber optic light guide extending outwardly from the transducer housing in a direction substantially perpendicular to the line between the extending the light source and the at least one light detector.
2. The transducer of claim 1, wherein the housing includes one or more recessed cutouts disposed between the light source and the at least one light detector.
3. The transducer of claim 1 further comprising an adhesive pad attached to the housing.
4. The transducer of claim 3, wherein the adhesive pad includes openings for the light source and the at least one light detector.
5. The transducer of claim 1 wherein the housing includes an adhesive applied to one surface.
US11/864,203 1999-03-12 2007-09-28 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation Abandoned US20080017800A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/864,203 US20080017800A1 (en) 1999-03-12 2007-09-28 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12384999P 1999-03-12 1999-03-12
US15131999P 1999-08-30 1999-08-30
US43414299A 1999-11-04 1999-11-04
US09/951,221 US7047054B2 (en) 1999-03-12 2001-09-14 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US11/384,615 US7313427B2 (en) 1999-03-12 2006-03-20 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation
US11/864,203 US20080017800A1 (en) 1999-03-12 2007-09-28 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/384,615 Continuation US7313427B2 (en) 1999-03-12 2006-03-20 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation

Publications (1)

Publication Number Publication Date
US20080017800A1 true US20080017800A1 (en) 2008-01-24

Family

ID=46278162

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/951,221 Expired - Fee Related US7047054B2 (en) 1999-03-12 2001-09-14 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US11/384,615 Expired - Fee Related US7313427B2 (en) 1999-03-12 2006-03-20 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation
US11/864,203 Abandoned US20080017800A1 (en) 1999-03-12 2007-09-28 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/951,221 Expired - Fee Related US7047054B2 (en) 1999-03-12 2001-09-14 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US11/384,615 Expired - Fee Related US7313427B2 (en) 1999-03-12 2006-03-20 Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation

Country Status (1)

Country Link
US (3) US7047054B2 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070073117A1 (en) * 2005-09-29 2007-03-29 Raridan William B Jr Medical sensor and technique for using the same
US20080117616A1 (en) * 2006-09-28 2008-05-22 Nellcor Puritan Bennett Inc. Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US20090005662A1 (en) * 2004-02-25 2009-01-01 Nellcor Puritan Bennett Inc Oximeter Ambient Light Cancellation
US20100125187A1 (en) * 2008-11-17 2010-05-20 Denso Corporation Blood constituent concentration detector and starter for transporter
US20100249550A1 (en) * 2009-03-25 2010-09-30 Neilcor Puritan Bennett LLC Method And Apparatus For Optical Filtering Of A Broadband Emitter In A Medical Sensor
US7884933B1 (en) 2010-05-05 2011-02-08 Revolutionary Business Concepts, Inc. Apparatus and method for determining analyte concentrations
US20110066013A1 (en) * 2009-09-16 2011-03-17 Analogic Corporation Physiological parameter monitoring apparatus
US8553223B2 (en) 2010-03-31 2013-10-08 Covidien Lp Biodegradable fibers for sensing
US8692992B2 (en) 2011-09-22 2014-04-08 Covidien Lp Faraday shield integrated into sensor bandage
US8726496B2 (en) 2011-09-22 2014-05-20 Covidien Lp Technique for remanufacturing a medical sensor
US8821397B2 (en) 2010-09-28 2014-09-02 Masimo Corporation Depth of consciousness monitor including oximeter
US20140339310A1 (en) * 2013-05-14 2014-11-20 Symbol Technologies, Inc. Apparatus for and method of electro-optically reading a target in the presence of ambient light by suppressing the ambient light
US20150025344A1 (en) * 2013-07-18 2015-01-22 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
US20160218866A1 (en) * 2015-01-27 2016-07-28 Qualcomm Incorporated Group key announcement and distribution for a data link group
US9775545B2 (en) 2010-09-28 2017-10-03 Masimo Corporation Magnetic electrical connector for patient monitors
CN107407603A (en) * 2015-03-25 2017-11-28 世美特株式会社 Infrared temperature sensor and the device using infrared temperature sensor
US9883824B2 (en) 2012-08-20 2018-02-06 Taiwan Biophotonic Corporation Detecting device
US10154815B2 (en) 2014-10-07 2018-12-18 Masimo Corporation Modular physiological sensors
WO2019127194A1 (en) * 2017-12-28 2019-07-04 中国科学院自动化研究所 Non-contact cerebral blood oxygen detecting system
US10368798B2 (en) * 2013-06-28 2019-08-06 North Carolina State University Systems and methods for determining sleep patterns and circadian rhythms
US10786157B2 (en) 2014-11-20 2020-09-29 Edwards Lifesciences Corporation Spectrophotometric sensor

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954756A1 (en) * 1999-11-17 2001-05-31 Odim Gmbh Device and method for examining biological tissue
CA2494030C (en) * 2002-07-26 2009-06-09 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
WO2004030480A1 (en) * 2002-10-01 2004-04-15 Nellcor Puritan Bennett Incorporated Headband with tension indicator
US7698909B2 (en) 2002-10-01 2010-04-20 Nellcor Puritan Bennett Llc Headband with tension indicator
US7047056B2 (en) * 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
US8412297B2 (en) * 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US8260389B2 (en) * 2003-10-15 2012-09-04 Hegln (Dalian) Pharmaceuticals, Inc. Bladder function monitoring methods, apparatuses, media and signals
WO2005034754A1 (en) * 2003-10-15 2005-04-21 The University Of British Columbia Methods and apparatus for urodynamic analysis
JP4556107B2 (en) * 2003-10-30 2010-10-06 ソニー株式会社 Imaging apparatus and method, and communication terminal apparatus
US7508497B2 (en) * 2003-11-26 2009-03-24 Meade Instruments Corporation Rangefinder with reduced noise receiver
US7280858B2 (en) * 2004-01-05 2007-10-09 Masimo Corporation Pulse oximetry sensor
US7194293B2 (en) 2004-03-08 2007-03-20 Nellcor Puritan Bennett Incorporated Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics
WO2006019911A1 (en) * 2004-07-26 2006-02-23 Sun Microsystems, Inc. Multi-chip module and single-chip module for chips and proximity connectors
US7706853B2 (en) * 2005-02-10 2010-04-27 Terumo Cardiovascular Systems Corporation Near infrared spectroscopy device with reusable portion
US7865223B1 (en) * 2005-03-14 2011-01-04 Peter Bernreuter In vivo blood spectrometry
US8055321B2 (en) * 2005-03-14 2011-11-08 Peter Bernreuter Tissue oximetry apparatus and method
EP1869737B1 (en) * 2005-03-16 2021-05-12 Davidson Instruments, Inc. High intensity fabry-perot sensor
US8432552B2 (en) * 2005-03-16 2013-04-30 Halliburton Energy Services, Inc. High intensity Fabry-Perot sensor
JP4720621B2 (en) * 2005-06-09 2011-07-13 セイコーエプソン株式会社 Laser light source device, display device, scanning display device, and projector
US7657294B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Compliant diaphragm medical sensor and technique for using the same
WO2007033318A2 (en) * 2005-09-13 2007-03-22 Edwards Lifesciences Corporation Continuous spectroscopic measurement of total hemoglobin
WO2007048039A2 (en) * 2005-10-21 2007-04-26 Cas Medical Systems, Inc. Method and apparatus for spectrophotometric based oximetry
WO2007079316A2 (en) * 2005-12-06 2007-07-12 Cas Medical Systems, Inc. Indicators for a spectrophotometric system
US7511259B2 (en) * 2006-04-24 2009-03-31 Northrop Grumman Corporation Smart integrated distributed light-powered process control system
WO2007141859A1 (en) * 2006-06-08 2007-12-13 Omron Healthcare Co., Ltd. Biological component measurement device capable of accurately noninvasively measuring biological component
WO2008016590A2 (en) * 2006-07-31 2008-02-07 Visualant, Inc. System and method of evaluating an object using electromagnetic energy
US8081304B2 (en) 2006-07-31 2011-12-20 Visualant, Inc. Method, apparatus, and article to facilitate evaluation of objects using electromagnetic energy
KR100810327B1 (en) 2006-09-05 2008-03-04 삼성전자주식회사 Optical module and optical comminunication system using the same
US8219170B2 (en) * 2006-09-20 2012-07-10 Nellcor Puritan Bennett Llc System and method for practicing spectrophotometry using light emitting nanostructure devices
US7869849B2 (en) 2006-09-26 2011-01-11 Nellcor Puritan Bennett Llc Opaque, electrically nonconductive region on a medical sensor
US7643858B2 (en) * 2006-09-28 2010-01-05 Nellcor Puritan Bennett Llc System and method for detection of brain edema using spectrophotometry
US8428674B2 (en) * 2006-11-14 2013-04-23 Cas Medical Systems, Inc. Apparatus for spectrometric based oximetry
KR100859981B1 (en) * 2007-01-19 2008-09-25 삼성전자주식회사 Photoplethysmography sensor
US8100834B2 (en) 2007-02-27 2012-01-24 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of a compartment for detecting conditions of a compartment syndrome
US8639309B2 (en) * 2007-07-31 2014-01-28 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of compartments and tissue
WO2008112220A1 (en) * 2007-03-08 2008-09-18 Davidson Instruments Inc. Apparatus and methods for monitoring combustion dynamics in a gas turbine engine
US20080220512A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Tunable laser-based spectroscopy system for non-invasively measuring body water content
US20100084557A1 (en) * 2007-05-01 2010-04-08 Urodynamix Technologies Ltd. Light intensity control for near infrared spectroscopy
US20090095926A1 (en) * 2007-10-12 2009-04-16 Macneish Iii William Jack Physiological parameter detector
US8380272B2 (en) * 2007-12-21 2013-02-19 Covidien Lp Physiological sensor
US8577434B2 (en) * 2007-12-27 2013-11-05 Covidien Lp Coaxial LED light sources
US8452364B2 (en) * 2007-12-28 2013-05-28 Covidien LLP System and method for attaching a sensor to a patient's skin
US8092993B2 (en) 2007-12-31 2012-01-10 Nellcor Puritan Bennett Llc Hydrogel thin film for use as a biosensor
JP5645669B2 (en) 2008-01-08 2014-12-24 ブルースカイ・メディカル・グループ・インコーポレーテッド Persistent variable negative pressure wound therapy and its control
WO2009114624A2 (en) 2008-03-12 2009-09-17 Bluesky Medical Group Inc. Negative pressure dressing and method of using same
US8364224B2 (en) 2008-03-31 2013-01-29 Covidien Lp System and method for facilitating sensor and monitor communication
US8437825B2 (en) * 2008-07-03 2013-05-07 Cercacor Laboratories, Inc. Contoured protrusion for improving spectroscopic measurement of blood constituents
US8630691B2 (en) 2008-08-04 2014-01-14 Cercacor Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
KR20110053993A (en) * 2008-08-07 2011-05-24 유니버시티 오브 매사추세츠 Spectroscopic sensors
ATE547980T1 (en) * 2008-09-25 2012-03-15 Nemodevices Ag DEVICE FOR DIAGNOSIS AND/OR THERAPY OF PHYSIOLOGICAL PROPERTIES OF A SELECTED PART OF THE BODY BY OPTICAL REFLECTION OR TRANSMISSION
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8532751B2 (en) * 2008-09-30 2013-09-10 Covidien Lp Laser self-mixing sensors for biological sensing
US20100081904A1 (en) * 2008-09-30 2010-04-01 Nellcor Puritan Bennett Llc Device And Method For Securing A Medical Sensor to An Infant's Head
US20100105998A1 (en) * 2008-10-28 2010-04-29 Cas Medical Systems, Inc. Method and apparatus for spectrophotometric based oximetry of spinal tissue
US8725226B2 (en) 2008-11-14 2014-05-13 Nonin Medical, Inc. Optical sensor path selection
WO2010061339A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Device and method for optically examining the interior of a turbid medium
US8111809B2 (en) 2009-01-29 2012-02-07 The Invention Science Fund I, Llc Diagnostic delivery service
US8130904B2 (en) 2009-01-29 2012-03-06 The Invention Science Fund I, Llc Diagnostic delivery service
US8812070B2 (en) * 2009-02-13 2014-08-19 Hutchinson Technology Incorporated Portable StO2 spectrometer
US8788002B2 (en) 2009-02-25 2014-07-22 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
EP3357419A1 (en) 2009-02-25 2018-08-08 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
TWI373324B (en) * 2009-05-05 2012-10-01 Univ Nat Chiao Tung Biomedical sensor
US20100317949A1 (en) * 2009-06-12 2010-12-16 02 Medtech, Inc. Optical coupler for non-invasive spectrophotometric patient monitoring
US9693717B2 (en) 2009-07-10 2017-07-04 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring of the lower gastrointestinal tract
US8688183B2 (en) 2009-09-03 2014-04-01 Ceracor Laboratories, Inc. Emitter driver for noninvasive patient monitor
US8494604B2 (en) * 2009-09-21 2013-07-23 Covidien Lp Wavelength-division multiplexing in a multi-wavelength photon density wave system
US8515511B2 (en) 2009-09-29 2013-08-20 Covidien Lp Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same
US9078610B2 (en) 2010-02-22 2015-07-14 Covidien Lp Motion energy harvesting with wireless sensors
US8874180B2 (en) * 2010-02-28 2014-10-28 Covidien Lp Ambient electromagnetic energy harvesting with wireless sensors
US8483788B2 (en) * 2010-02-28 2013-07-09 Covidien Lp Motion compensation in a sensor
US8428676B2 (en) 2010-03-31 2013-04-23 Covidien Lp Thermoelectric energy harvesting with wireless sensors
US8319401B2 (en) 2010-04-30 2012-11-27 Nellcor Puritan Bennett Llc Air movement energy harvesting with wireless sensors
JP2013544588A (en) 2010-11-03 2013-12-19 ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション Determination of tissue oxygenation in vivo
US20120113411A1 (en) * 2010-11-09 2012-05-10 Nellcor Puritan Bennett Llc Optical fiber sensors
US10321862B2 (en) 2011-02-13 2019-06-18 Cas Medical Systems, Inc. NIRS sensor assembly including electrically conductive and optically transparent EMI shielding
WO2012135079A1 (en) 2011-03-25 2012-10-04 Hutchinson Technology Incorporated Systems and methods for measuring oxygenation
CH704900A1 (en) 2011-05-05 2012-11-15 Nemo Devices Ag Measuring device for measuring cerebral parameters.
US8498507B2 (en) 2011-05-13 2013-07-30 Kestrel Labs, Inc. Anti-reflective launch optics for laser to fiber coupling in a photoplethysmograpic device
US8805470B2 (en) 2011-07-11 2014-08-12 Covidien Lp Device with encapsulated gel
US8888207B2 (en) 2012-02-10 2014-11-18 Visualant, Inc. Systems, methods and articles related to machine-readable indicia and symbols
US20130317368A1 (en) 2012-03-12 2013-11-28 Ivwatch, Llc System for Mitigating the Effects of Tissue Blood Volume Changes to Aid in Diagnosing Infiltration or Extravasation in Animalia Tissue
US20130253333A1 (en) * 2012-03-22 2013-09-26 Nellcor Puritan Bennett Llc Tissue interface elements for application of optical signals into tissue of a patient
US9907494B2 (en) 2012-04-18 2018-03-06 Hutchinson Technology Incorporated NIRS device with optical wavelength and path length correction
US10542903B2 (en) 2012-06-07 2020-01-28 Masimo Corporation Depth of consciousness monitor
CH707194A1 (en) 2012-11-06 2014-05-15 Nemodevices Ag Measuring device for determining cerebral parameters.
EP2928371B1 (en) 2012-12-10 2021-06-02 Edwards Lifesciences Corporation Method for spectrophotometrically determining a blood oxygen parameter
US9888873B2 (en) * 2012-12-10 2018-02-13 Cas Medical Systems, Inc. NIRS sensor assembly including EMI shielding
US8922788B2 (en) 2012-12-22 2014-12-30 Covidien Lp Methods and systems for determining a probe-off condition in a medical device
US9316581B2 (en) 2013-02-04 2016-04-19 Visualant, Inc. Method, apparatus, and article to facilitate evaluation of substances using electromagnetic energy
US9041920B2 (en) 2013-02-21 2015-05-26 Visualant, Inc. Device for evaluation of fluids using electromagnetic energy
US9560995B2 (en) 2013-02-25 2017-02-07 Covidien Lp Methods and systems for determining a probe-off condition in a medical device
WO2014165003A1 (en) 2013-03-12 2014-10-09 Visualant, Inc. Systems and methods for fluid analysis using electromagnetic energy
PT2999402T (en) 2013-05-22 2023-03-07 Luciole Medical AG Measurement system and method for measuring parameters in a body tissue
USD763939S1 (en) 2014-04-02 2016-08-16 Cephalogics, LLC Optical sensor array liner with optical sensor array pad
USD763938S1 (en) 2014-04-02 2016-08-16 Cephalogics, LLC Optical sensor array
WO2015161242A1 (en) * 2014-04-18 2015-10-22 The General Hospital Corporation System and method for improved light delivery to and from subjects
US9639742B2 (en) * 2014-04-28 2017-05-02 Microsoft Technology Licensing, Llc Creation of representative content based on facial analysis
US9773156B2 (en) 2014-04-29 2017-09-26 Microsoft Technology Licensing, Llc Grouping and ranking images based on facial recognition data
KR102412896B1 (en) 2014-12-18 2022-06-24 삼성전자 주식회사 Method and apparatus for supporting facility control of terminal
WO2016111512A1 (en) 2015-01-09 2016-07-14 Samsung Electronics Co., Ltd. Semiconductor package and method of manufacturing the same
US20160266340A1 (en) * 2015-03-10 2016-09-15 Finisar Corporation Latching and emi shielding mechanism for an optical module
US10499838B2 (en) * 2015-04-24 2019-12-10 Drexel University Non-invasive brain water monitoring device for cerebral edema and cerebral autoregulation monitoring system and method
KR102231784B1 (en) 2015-08-24 2021-03-23 삼성전자주식회사 Apparatus and method for measuring reference spectrum for analyzing sample, apparatus and method for analyzing sample
JP6609737B2 (en) * 2015-09-25 2019-11-27 株式会社NeU Biological light measurement device, information processing program, and information processing method
US10638960B2 (en) 2015-10-26 2020-05-05 Reveal Biosensors, Inc. Optical physiologic sensor methods
WO2017149275A1 (en) * 2016-03-02 2017-09-08 Bae Systems Plc Co-aligning laterally displaced radiation beams
JP2019527566A (en) 2016-05-13 2019-10-03 スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company Wound monitoring and treatment device using sensor
US10506926B2 (en) 2017-02-18 2019-12-17 Arc Devices Limited Multi-vital sign detector in an electronic medical records system
US10492684B2 (en) 2017-02-21 2019-12-03 Arc Devices Limited Multi-vital-sign smartphone system in an electronic medical records system
WO2018162736A1 (en) 2017-03-09 2018-09-13 Smith & Nephew Plc Wound dressing, patch member and method of sensing one or more wound parameters
EP3592230A1 (en) 2017-03-09 2020-01-15 Smith & Nephew PLC Apparatus and method for imaging blood in a target region of tissue
AU2018253383A1 (en) 2017-04-11 2019-10-31 Smith & Nephew Plc Component positioning and stress relief for sensor enabled wound dressings
AU2018269112A1 (en) 2017-05-15 2019-11-21 Smith & Nephew Plc Wound analysis device and method
JP7189159B2 (en) 2017-06-23 2022-12-13 スミス アンド ネフュー ピーエルシー Sensor placement for sensor-enabled wound monitoring or therapy
GB201804502D0 (en) 2018-03-21 2018-05-02 Smith & Nephew Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
GB201809007D0 (en) 2018-06-01 2018-07-18 Smith & Nephew Restriction of sensor-monitored region for sensor-enabled wound dressings
CN107440726B (en) * 2017-07-27 2021-01-12 珠海柯诺医疗科技有限公司 Pressure-releasing protection consumable based on laser hemostix
US10602987B2 (en) 2017-08-10 2020-03-31 Arc Devices Limited Multi-vital-sign smartphone system in an electronic medical records system
EP3681376A1 (en) 2017-09-10 2020-07-22 Smith & Nephew PLC Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings
GB201718870D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Inc Sensor enabled wound therapy dressings and systems
CN111132605B (en) 2017-09-27 2023-05-16 史密夫及内修公开有限公司 PH sensing for negative pressure wound monitoring and treatment device implementing sensor
WO2019072531A1 (en) 2017-09-28 2019-04-18 Smith & Nephew Plc Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
CN111343950A (en) 2017-11-15 2020-06-26 史密夫及内修公开有限公司 Integrated wound monitoring and/or therapy dressing and system implementing sensors
US10485431B1 (en) 2018-05-21 2019-11-26 ARC Devices Ltd. Glucose multi-vital-sign system in an electronic medical records system
EP3705041A1 (en) * 2019-03-05 2020-09-09 Luciole Medical AG Sensor assembly
US11589764B1 (en) 2019-10-30 2023-02-28 Brigham Young University Methods and devices for aligning miniaturized spectrometers and impedance sensors in wearable devices
US11471078B1 (en) 2019-10-30 2022-10-18 Brigham Young University Miniaturized spectrometers for wearable devices
US11630316B1 (en) 2019-10-30 2023-04-18 Brigham Young University Miniaturized collimators
US11877845B1 (en) 2019-10-30 2024-01-23 Brigham Young University Miniaturized spectrometers on transparent substrates
US11504014B2 (en) 2020-06-01 2022-11-22 Arc Devices Limited Apparatus and methods for measuring blood pressure and other vital signs via a finger
CN113456067B (en) * 2021-06-24 2023-06-23 江西科莱富健康科技有限公司 Method, system and computer equipment for measuring in-vitro hemoglobin concentration

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223680A (en) * 1977-06-28 1980-09-23 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs in vivo
US4621643A (en) * 1982-09-02 1986-11-11 Nellcor Incorporated Calibrated optical oximeter probe
US4700708A (en) * 1982-09-02 1987-10-20 Nellcor Incorporated Calibrated optical oximeter probe
US4725147A (en) * 1984-09-17 1988-02-16 Somanetics Corporation Calibration method and apparatus for optical-response tissue-examination instrument
US4768516A (en) * 1983-10-14 1988-09-06 Somanetics Corporation Method and apparatus for in vivo evaluation of tissue composition
US4770179A (en) * 1982-09-02 1988-09-13 Nellcor Incorporated Calibrated optical oximeter probe
US4817623A (en) * 1983-10-14 1989-04-04 Somanetics Corporation Method and apparatus for interpreting optical response data
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US4913150A (en) * 1986-08-18 1990-04-03 Physio-Control Corporation Method and apparatus for the automatic calibration of signals employed in oximetry
US5054488A (en) * 1989-04-20 1991-10-08 Nicolay Gmbh Optoelectronic sensor for producing electrical signals representative of physiological values
US5080098A (en) * 1989-12-18 1992-01-14 Sentinel Monitoring, Inc. Non-invasive sensor
US5088493A (en) * 1984-08-07 1992-02-18 Sclavo, S.P.A. Multiple wavelength light photometer for non-invasive monitoring
US5140989A (en) * 1983-10-14 1992-08-25 Somanetics Corporation Examination instrument for optical-response diagnostic apparatus
US5209230A (en) * 1990-10-19 1993-05-11 Nellcor Incorporated Adhesive pulse oximeter sensor with reusable portion
US5217013A (en) * 1983-10-14 1993-06-08 Somanetics Corporation Patient sensor for optical cerebral oximeter and the like
US5246003A (en) * 1991-08-28 1993-09-21 Nellcor Incorporated Disposable pulse oximeter sensor
US5263244A (en) * 1992-04-17 1993-11-23 Gould Inc. Method of making a flexible printed circuit sensor assembly for detecting optical pulses
US5277181A (en) * 1991-12-12 1994-01-11 Vivascan Corporation Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis
US5421329A (en) * 1994-04-01 1995-06-06 Nellcor, Inc. Pulse oximeter sensor optimized for low saturation
US5429129A (en) * 1991-08-22 1995-07-04 Sensor Devices, Inc. Apparatus for determining spectral absorption by a specific substance in a fluid
US5465714A (en) * 1993-05-20 1995-11-14 Somanetics Corporation Electro-optical sensor for spectrophotometric medical devices
US5477853A (en) * 1992-12-01 1995-12-26 Somanetics Corporation Temperature compensation method and apparatus for spectroscopic devices
US5482034A (en) * 1993-05-28 1996-01-09 Somanetics Corporation Method and apparatus for spectrophotometric cerebral oximetry and the like
US5520177A (en) * 1993-03-26 1996-05-28 Nihon Kohden Corporation Oximeter probe
US5542421A (en) * 1992-07-31 1996-08-06 Frederick Erdman Association Method and apparatus for cardiovascular diagnosis
US5752914A (en) * 1996-05-28 1998-05-19 Nellcor Puritan Bennett Incorporated Continuous mesh EMI shield for pulse oximetry sensor
US5758644A (en) * 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US5795292A (en) * 1994-10-14 1998-08-18 Somanetics Corporation Method for improving signal-to-noise in clinical spectrometric procedures
US5803909A (en) * 1994-10-06 1998-09-08 Hitachi, Ltd. Optical system for measuring metabolism in a body and imaging method
US5817008A (en) * 1996-10-31 1998-10-06 Spacelabs Medical, Inc. Conformal pulse oximetry sensor and monitor
US5853370A (en) * 1996-09-13 1998-12-29 Non-Invasive Technology, Inc. Optical system and method for non-invasive imaging of biological tissue
US5902235A (en) * 1989-03-29 1999-05-11 Somanetics Corporation Optical cerebral oximeter
US6095974A (en) * 1995-07-21 2000-08-01 Respironics, Inc. Disposable fiber optic probe
US6615065B1 (en) * 1998-10-13 2003-09-02 Somanetics Corporation Multi-channel non-invasive tissue oximeter

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638640A (en) * 1967-11-01 1972-02-01 Robert F Shaw Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths
US3674008A (en) * 1970-07-13 1972-07-04 Battelle Development Corp Quantitative pulsed transilluminator and method of operation
US4105021A (en) * 1976-08-13 1978-08-08 Joseph H. Allen Method and arrangement for measuring blood pressure
US4206764A (en) * 1976-12-08 1980-06-10 Weisman & Allen Method and apparatus for analyzing cardiovascular systems
US5139025A (en) * 1983-10-14 1992-08-18 Somanetics Corporation Method and apparatus for in vivo optical spectroscopic examination
US4570638A (en) * 1983-10-14 1986-02-18 Somanetics Corporation Method and apparatus for spectral transmissibility examination and analysis
JPS60143398U (en) * 1984-03-05 1985-09-24 三菱電線工業株式会社 Shielding material
US4690492A (en) * 1984-09-04 1987-09-01 Oximetrix, Inc. Optical coupling
US5259381A (en) * 1986-08-18 1993-11-09 Physio-Control Corporation Apparatus for the automatic calibration of signals employed in oximetry
JPS6365845A (en) * 1986-09-05 1988-03-24 ミノルタ株式会社 Oximeter apparatus
JPS63277039A (en) * 1987-05-08 1988-11-15 Hamamatsu Photonics Kk Diagnostic apparatus
US4907876A (en) 1987-05-08 1990-03-13 Hamamatsu Photonics Kabushiki Kaisha Examination apparatus for measuring oxygenation in body organs
US4805623A (en) * 1987-09-04 1989-02-21 Vander Corporation Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment
US4848901A (en) * 1987-10-08 1989-07-18 Critikon, Inc. Pulse oximeter sensor control system
US5060098A (en) * 1988-04-18 1991-10-22 Hitachi, Ltd. Magnetic recorder provided with a magnetic head slider having a non-magnetic oxide of spinel structure
US5873821A (en) * 1992-05-18 1999-02-23 Non-Invasive Technology, Inc. Lateralization spectrophotometer
JPH06103257B2 (en) * 1988-12-19 1994-12-14 大塚電子株式会社 Method and apparatus for measuring absorption coefficient of substance using light scattering
US5119815A (en) * 1988-12-21 1992-06-09 Nim, Incorporated Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation
US5782755A (en) 1993-11-15 1998-07-21 Non-Invasive Technology, Inc. Monitoring one or more solutes in a biological system using optical techniques
US4907676A (en) * 1989-04-03 1990-03-13 Shirdavani Hossain A Low profile, remotely operable valve
CA2025330C (en) 1989-09-18 2002-01-22 David W. Osten Characterizing biological matter in a dynamic condition using near infrared spectroscopy
US5058588A (en) * 1989-09-19 1991-10-22 Hewlett-Packard Company Oximeter and medical sensor therefor
US5203329A (en) * 1989-10-05 1993-04-20 Colin Electronics Co., Ltd. Noninvasive reflectance oximeter sensor providing controlled minimum optical detection depth
GB9003097D0 (en) * 1990-02-12 1990-04-11 Scient Generics Ltd Solid state laser diode light source
EP0613652B1 (en) * 1990-02-15 1997-04-16 Hewlett-Packard GmbH Apparatus and method for non-invasive measurement of oxygen saturation
US4973150A (en) * 1990-03-23 1990-11-27 Eastman Kodak Company Film constraint and film writing system
US5218982A (en) * 1991-01-05 1993-06-15 Matsumura Kenji Handy hut
JPH04106748U (en) * 1991-02-28 1992-09-14 株式会社島津製作所 Optical biomeasuring device
DE69123954T2 (en) 1991-03-07 1997-04-30 Hamamatsu Photonics Kk Arrangement for measuring the oxygen content in the tissue
US5188106A (en) * 1991-03-08 1993-02-23 Telectronics Pacing Systems, Inc. Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
US5226417A (en) * 1991-03-11 1993-07-13 Nellcor, Inc. Apparatus for the detection of motion transients
US5237994A (en) * 1991-03-12 1993-08-24 Square One Technology Integrated lead frame pulse oximetry sensor
US5995855A (en) * 1998-02-11 1999-11-30 Masimo Corporation Pulse oximetry sensor adapter
US5638818A (en) * 1991-03-21 1997-06-17 Masimo Corporation Low noise optical probe
US5153669A (en) * 1991-03-27 1992-10-06 Hughes Danbury Optical Systems, Inc. Three wavelength optical measurement apparatus and method
US5218962A (en) 1991-04-15 1993-06-15 Nellcor Incorporated Multiple region pulse oximetry probe and oximeter
DE4140952A1 (en) * 1991-12-12 1993-06-17 Rieter Ingolstadt Spinnerei METHOD AND DEVICE FOR CLEANING THE SENSOR SURFACES OF A YARN MONITORING
US5460182A (en) * 1992-09-14 1995-10-24 Sextant Medical Corporation Tissue penetrating apparatus and methods
US5311013A (en) * 1992-10-15 1994-05-10 Abbott Laboratories Optical fiber distribution system for an optical fiber sensor in a luminescent sensor system
WO1994012096A1 (en) 1992-12-01 1994-06-09 Somanetics Corporation Patient sensor for optical cerebral oximeters
DE4305688C2 (en) * 1993-02-25 1994-04-21 Voith Gmbh J M Device and method for changing the flow resistance of a throttle device for fluid flows
JP3577335B2 (en) * 1993-06-02 2004-10-13 浜松ホトニクス株式会社 Scattering absorber measurement method and device
JP3433498B2 (en) * 1993-06-02 2003-08-04 浜松ホトニクス株式会社 Method and apparatus for measuring internal information of scattering medium
US5417213A (en) * 1993-06-07 1995-05-23 Prince; Martin R. Magnetic resonance arteriography with dynamic intravenous contrast agents
US5421549A (en) * 1993-12-30 1995-06-06 Richards; John W. Support stand for optical equipment
US5632273A (en) * 1994-02-04 1997-05-27 Hamamatsu Photonics K.K. Method and means for measurement of biochemical components
DE4417639A1 (en) * 1994-05-19 1995-11-23 Boehringer Mannheim Gmbh Analysis of concns. of substances in a biological sample
JP3315814B2 (en) * 1994-06-09 2002-08-19 トヨタ自動車株式会社 Vehicle control device, clutch slip control device and idle speed control device
JP2780935B2 (en) 1994-09-22 1998-07-30 浜松ホトニクス株式会社 Method and apparatus for measuring concentration of absorption component of scattering absorber
JP3433534B2 (en) * 1994-11-07 2003-08-04 浜松ホトニクス株式会社 Method and apparatus for measuring scattering and absorption characteristics in scattering medium
DE69627477T2 (en) * 1995-01-03 2004-03-18 Non-Invasive Technology, Inc. OPTICAL COUPLING DEVICE FOR IN-VIVO EXAMINATION OF BIOLOGICAL TISSUES
US5692503A (en) * 1995-03-10 1997-12-02 Kuenstner; J. Todd Method for noninvasive (in-vivo) total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination
US5524617A (en) 1995-03-14 1996-06-11 Nellcor, Incorporated Isolated layer pulse oximetry
DE19612425C2 (en) * 1995-03-31 2000-08-31 Nihon Kohden Corp Apparatus for measuring hemoglobin concentration
US5582755A (en) * 1995-04-04 1996-12-10 Tridelta Industries, Inc. Apparatus and method for classifying a medium in a cooking chamber
US5774213A (en) * 1995-04-21 1998-06-30 Trebino; Rick P. Techniques for measuring difference of an optical property at two wavelengths by modulating two sources to have opposite-phase components at a common frequency
GB9517366D0 (en) * 1995-08-24 1995-10-25 Johnson & Johnson Medical Method of quantatively determining one or more characteristics of a substance
DE19537646C2 (en) * 1995-10-10 1998-09-17 Hewlett Packard Gmbh Method and device for detecting falsified measurement values in pulse oximetry for measuring oxygen saturation
US5839439A (en) * 1995-11-13 1998-11-24 Nellcor Puritan Bennett Incorporated Oximeter sensor with rigid inner housing and pliable overmold
US5872294A (en) * 1996-01-11 1999-02-16 General Electric Company Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use
US5891026A (en) * 1996-01-29 1999-04-06 Ntc Technology Inc. Extended life disposable pulse oximetry sensor and method of making
US5758844A (en) * 1996-05-28 1998-06-02 Boeing North American, Inc. Vertical/short take-off and landing (V/STOL) air vehicle capable of providing high speed horizontal flight
US5684296A (en) * 1996-06-17 1997-11-04 Optical Systems Industries, Inc. Fiber optic liquid sensing system
US5879294A (en) 1996-06-28 1999-03-09 Hutchinson Technology Inc. Tissue chromophore measurement system
EP0923335B1 (en) * 1996-07-08 2006-08-23 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US6415166B1 (en) * 1997-09-26 2002-07-02 Datex-Ohmeda, Inc. Photoplethysmographic device with remote facsimile
US6014576A (en) * 1998-02-27 2000-01-11 Datex-Ohmeda, Inc. Segmented photoplethysmographic sensor with universal probe-end
WO2000018290A1 (en) * 1998-09-29 2000-04-06 Mallinckrodt Inc. Oximeter sensor with encoded temperature characteristic
EP1485012B1 (en) 2002-02-27 2015-01-28 Covidien LP Method and apparatus for determining cerebral oxygen saturation

Patent Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321930A (en) * 1977-06-28 1982-03-30 Duke University, Inc. Apparatus for monitoring metabolism in body organs
US4380240A (en) * 1977-06-28 1983-04-19 Duke University, Inc. Apparatus for monitoring metabolism in body organs
US4510938A (en) * 1977-06-28 1985-04-16 Duke University, Inc. Body-mounted light source-detector apparatus
US4223680A (en) * 1977-06-28 1980-09-23 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs in vivo
US4770179A (en) * 1982-09-02 1988-09-13 Nellcor Incorporated Calibrated optical oximeter probe
US4621643A (en) * 1982-09-02 1986-11-11 Nellcor Incorporated Calibrated optical oximeter probe
US4700708A (en) * 1982-09-02 1987-10-20 Nellcor Incorporated Calibrated optical oximeter probe
US5140989A (en) * 1983-10-14 1992-08-25 Somanetics Corporation Examination instrument for optical-response diagnostic apparatus
US4768516A (en) * 1983-10-14 1988-09-06 Somanetics Corporation Method and apparatus for in vivo evaluation of tissue composition
US4817623A (en) * 1983-10-14 1989-04-04 Somanetics Corporation Method and apparatus for interpreting optical response data
US5217013A (en) * 1983-10-14 1993-06-08 Somanetics Corporation Patient sensor for optical cerebral oximeter and the like
US5088493A (en) * 1984-08-07 1992-02-18 Sclavo, S.P.A. Multiple wavelength light photometer for non-invasive monitoring
US4725147A (en) * 1984-09-17 1988-02-16 Somanetics Corporation Calibration method and apparatus for optical-response tissue-examination instrument
US4913150A (en) * 1986-08-18 1990-04-03 Physio-Control Corporation Method and apparatus for the automatic calibration of signals employed in oximetry
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US5902235A (en) * 1989-03-29 1999-05-11 Somanetics Corporation Optical cerebral oximeter
US5054488A (en) * 1989-04-20 1991-10-08 Nicolay Gmbh Optoelectronic sensor for producing electrical signals representative of physiological values
US5080098A (en) * 1989-12-18 1992-01-14 Sentinel Monitoring, Inc. Non-invasive sensor
US5209230A (en) * 1990-10-19 1993-05-11 Nellcor Incorporated Adhesive pulse oximeter sensor with reusable portion
US5429129A (en) * 1991-08-22 1995-07-04 Sensor Devices, Inc. Apparatus for determining spectral absorption by a specific substance in a fluid
US5246003A (en) * 1991-08-28 1993-09-21 Nellcor Incorporated Disposable pulse oximeter sensor
US5277181A (en) * 1991-12-12 1994-01-11 Vivascan Corporation Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis
US5263244A (en) * 1992-04-17 1993-11-23 Gould Inc. Method of making a flexible printed circuit sensor assembly for detecting optical pulses
US5542421A (en) * 1992-07-31 1996-08-06 Frederick Erdman Association Method and apparatus for cardiovascular diagnosis
US5477853A (en) * 1992-12-01 1995-12-26 Somanetics Corporation Temperature compensation method and apparatus for spectroscopic devices
US5520177A (en) * 1993-03-26 1996-05-28 Nihon Kohden Corporation Oximeter probe
US5465714A (en) * 1993-05-20 1995-11-14 Somanetics Corporation Electro-optical sensor for spectrophotometric medical devices
US5482034A (en) * 1993-05-28 1996-01-09 Somanetics Corporation Method and apparatus for spectrophotometric cerebral oximetry and the like
US5421329A (en) * 1994-04-01 1995-06-06 Nellcor, Inc. Pulse oximeter sensor optimized for low saturation
US5803909A (en) * 1994-10-06 1998-09-08 Hitachi, Ltd. Optical system for measuring metabolism in a body and imaging method
US5795292A (en) * 1994-10-14 1998-08-18 Somanetics Corporation Method for improving signal-to-noise in clinical spectrometric procedures
US5758644A (en) * 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US6095974A (en) * 1995-07-21 2000-08-01 Respironics, Inc. Disposable fiber optic probe
US5752914A (en) * 1996-05-28 1998-05-19 Nellcor Puritan Bennett Incorporated Continuous mesh EMI shield for pulse oximetry sensor
US5853370A (en) * 1996-09-13 1998-12-29 Non-Invasive Technology, Inc. Optical system and method for non-invasive imaging of biological tissue
US5817008A (en) * 1996-10-31 1998-10-06 Spacelabs Medical, Inc. Conformal pulse oximetry sensor and monitor
US6615065B1 (en) * 1998-10-13 2003-09-02 Somanetics Corporation Multi-channel non-invasive tissue oximeter

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005662A1 (en) * 2004-02-25 2009-01-01 Nellcor Puritan Bennett Inc Oximeter Ambient Light Cancellation
US8874181B2 (en) 2004-02-25 2014-10-28 Covidien Lp Oximeter ambient light cancellation
US8315684B2 (en) 2004-02-25 2012-11-20 Covidien Lp Oximeter ambient light cancellation
US20070073126A1 (en) * 2005-09-29 2007-03-29 Raridan William B Jr Medical sensor and technique for using the same
US20070073117A1 (en) * 2005-09-29 2007-03-29 Raridan William B Jr Medical sensor and technique for using the same
US8600469B2 (en) 2005-09-29 2013-12-03 Covidien Lp Medical sensor and technique for using the same
US20110130638A1 (en) * 2005-09-29 2011-06-02 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US20080117616A1 (en) * 2006-09-28 2008-05-22 Nellcor Puritan Bennett Inc. Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US7796403B2 (en) 2006-09-28 2010-09-14 Nellcor Puritan Bennett Llc Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US8306595B2 (en) 2008-11-17 2012-11-06 Denso Corporation Blood constituent concentration detector and starter for transporter
US20100125187A1 (en) * 2008-11-17 2010-05-20 Denso Corporation Blood constituent concentration detector and starter for transporter
US20100249550A1 (en) * 2009-03-25 2010-09-30 Neilcor Puritan Bennett LLC Method And Apparatus For Optical Filtering Of A Broadband Emitter In A Medical Sensor
US8521244B2 (en) 2009-09-16 2013-08-27 Analogic Corporation Physiological parameter monitoring apparatus
US20110066013A1 (en) * 2009-09-16 2011-03-17 Analogic Corporation Physiological parameter monitoring apparatus
US8553223B2 (en) 2010-03-31 2013-10-08 Covidien Lp Biodegradable fibers for sensing
US8199322B2 (en) 2010-05-05 2012-06-12 Revolutionary Business Concepts, Inc. Apparatus and method for determining analyte concentrations
US7884933B1 (en) 2010-05-05 2011-02-08 Revolutionary Business Concepts, Inc. Apparatus and method for determining analyte concentrations
US8821397B2 (en) 2010-09-28 2014-09-02 Masimo Corporation Depth of consciousness monitor including oximeter
US9775545B2 (en) 2010-09-28 2017-10-03 Masimo Corporation Magnetic electrical connector for patient monitors
US11717210B2 (en) 2010-09-28 2023-08-08 Masimo Corporation Depth of consciousness monitor including oximeter
US10531811B2 (en) 2010-09-28 2020-01-14 Masimo Corporation Depth of consciousness monitor including oximeter
US9538949B2 (en) 2010-09-28 2017-01-10 Masimo Corporation Depth of consciousness monitor including oximeter
US8726496B2 (en) 2011-09-22 2014-05-20 Covidien Lp Technique for remanufacturing a medical sensor
US8692992B2 (en) 2011-09-22 2014-04-08 Covidien Lp Faraday shield integrated into sensor bandage
US9610040B2 (en) 2011-09-22 2017-04-04 Covidien Lp Remanufactured medical sensor with flexible Faraday shield
US9883824B2 (en) 2012-08-20 2018-02-06 Taiwan Biophotonic Corporation Detecting device
US20140339310A1 (en) * 2013-05-14 2014-11-20 Symbol Technologies, Inc. Apparatus for and method of electro-optically reading a target in the presence of ambient light by suppressing the ambient light
US9016578B2 (en) * 2013-05-14 2015-04-28 Symbol Technologies, Inc. Apparatus for and method of electro-optically reading a target in the presence of ambient light by suppressing the ambient light
US10368798B2 (en) * 2013-06-28 2019-08-06 North Carolina State University Systems and methods for determining sleep patterns and circadian rhythms
US11357445B2 (en) 2013-06-28 2022-06-14 North Carolina State University Systems and methods for determining sleep patterns and circadian rhythms
US10918321B2 (en) 2013-07-18 2021-02-16 Edwards Lifesciences Corporation Method for spectrophotometric blood oxygenation monitoring
US9848808B2 (en) * 2013-07-18 2017-12-26 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
US20150025344A1 (en) * 2013-07-18 2015-01-22 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
US10154815B2 (en) 2014-10-07 2018-12-18 Masimo Corporation Modular physiological sensors
US10765367B2 (en) 2014-10-07 2020-09-08 Masimo Corporation Modular physiological sensors
US11717218B2 (en) 2014-10-07 2023-08-08 Masimo Corporation Modular physiological sensor
US10786157B2 (en) 2014-11-20 2020-09-29 Edwards Lifesciences Corporation Spectrophotometric sensor
US20160218866A1 (en) * 2015-01-27 2016-07-28 Qualcomm Incorporated Group key announcement and distribution for a data link group
CN107407603A (en) * 2015-03-25 2017-11-28 世美特株式会社 Infrared temperature sensor and the device using infrared temperature sensor
WO2019127194A1 (en) * 2017-12-28 2019-07-04 中国科学院自动化研究所 Non-contact cerebral blood oxygen detecting system
US11432749B2 (en) 2017-12-28 2022-09-06 Institute Of Automation, Chinese Academy Of Sciences Non-contact brain blood oxygen detecting system

Also Published As

Publication number Publication date
US7047054B2 (en) 2006-05-16
US20060195024A1 (en) 2006-08-31
US7313427B2 (en) 2007-12-25
US20020016536A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
US7313427B2 (en) Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation
EP1080683A2 (en) Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US8428674B2 (en) Apparatus for spectrometric based oximetry
EP2672893B1 (en) Nirs sensor assembly including electrically conductive and optically transparent emi shielding
US8965472B2 (en) Method and apparatus for spectrophotometric based oximetry
US6253097B1 (en) Noninvasive medical monitoring instrument using surface emitting laser devices
CA2221446C (en) Optical sensor including information element
US7236813B2 (en) Optical device
AU2006247746B2 (en) Improved method for spectrophotometric blood oxygenation monitoring
AU712825B2 (en) Active pulse blood constituent monitoring
EP0693900B1 (en) System and method for noninvasive hematocrit monitoring
EP0745348B1 (en) Instrumented laser diode probe connector
WO2005010568A2 (en) Optical vital signs monitor
JP2007532188A (en) Photoplethysmography using spatially uniform multicolor sources
EP1219241A4 (en) Stethoscope
US20100076281A1 (en) Device and method for monitoring blood parameters
EP0702931A1 (en) Noninvasive medical monitoring instrument
Kästle et al. A new family of sensors for pulse oximetry
JP4393568B2 (en) Pulse wave measuring instrument
McEwen et al. Noninvasive monitoring with strongly absorbed light
JPH04158843A (en) Nontrespass type oxymeter of pulse type and its measurement technique
IL201199A (en) Method for monitoring blood parameters

Legal Events

Date Code Title Description
AS Assignment

Owner name: CAS MEDICAL SYSTEMS, INC., CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BENNI, PAUL;REEL/FRAME:020030/0216

Effective date: 20010816

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC (AS SUCCESSOR-

Free format text: SECURITY INTEREST;ASSIGNOR:CAS MEDICAL SYSTEMS, INC.;REEL/FRAME:038115/0439

Effective date: 20160328

AS Assignment

Owner name: SOLAR CAPITAL LTD., AS SUCCESSOR AGENT, NEW YORK

Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS RETIRING AGENT;REEL/FRAME:038711/0067

Effective date: 20160513